Working reference protocols from Dr. Boris Zusin, DDS, FAGD, MBA, MS, Diplomate, American Board of Dental Sleep Medicine (ABDSM), for colleagues who refer to or co-treat with our practice. Each protocol states when to use it, the steps, the cautions, and an evidence summary, with sources.
For clinicians only. This page is reference information for licensed healthcare professionals. It is not patient advice and does not replace your clinical judgment or the manufacturer's instructions for use.
Restorative
Managing sensitivity after crown preparation: IDS vs. desensitizer vs. calcium hydroxide
Scope: Selecting a dentin-sealing strategy for a vital abutment, based on the planned luting strategy.
Conventionally or self-adhesively cemented crowns where comfort is the main goal: glutaraldehyde/HEMA (Gluma-type) desensitizer.
Long interim period before delivery: a desensitizer (glutaraldehyde/HEMA preferred because it does not impair resin-cement bond).
Protocol
Control etiology first: treat active periodontal disease, correct traumatic hygiene, and verify provisional margins and occlusion.
If IDS: isolate, apply the dentin bonding agent to freshly cut dentin immediately after preparation, add a flowable resin coat when using simplified/universal adhesives, light-cure, and protect through the provisional phase. At delivery, refresh the surface (remove the oxygen-inhibited layer and contamination) before luting.
If desensitizer: apply 5% glutaraldehyde / 35% HEMA to the cut dentin per manufacturer dwell time, gently dry to a glossy non-pooled surface, then provisionalize.
Desensitizer technique and mechanism. Keep the dentin moist but not desiccated (HEMA carries glutaraldehyde into the tubules), rub on with a microbrush or cotton pellet and leave it to react for the manufacturer dwell time (30–60 s; 60 s in one hypersensitivity RCT, in one or two coats), air-dry until the gloss disappears and rinse and dry per the instructions; it is not light-cured. Glutaraldehyde coagulates plasma proteins in dentinal fluid, forming septa within the tubules to roughly 200 µm depth. It does not interfere with impression polymerization or alter preparation geometry. A split-mouth RCT on full-crown preparations found Gluma and diode laser equally effective.
Know its limits. Gluma seals chemically rather than creating a reinforced hybrid layer, so it is not a bond-strength substitute for adhesive IDS. A single application gives relief for up to about 30 days and outperformed fluoride varnish at 7 days in a meta-analysis, but alone it was the least durable option in a 9-month trial (scores drifting toward baseline), whereas combining it with an Er:YAG laser gave the most sustained relief. Effects up to 6 months have been reported in hypersensitivity trials; reapply at delivery or if symptoms recur rather than on a fixed schedule. In a 180-day RCT, adding adhesive and flowable sealing layers over Gluma gave no measurable extra benefit. Glutaraldehyde and HEMA are soft-tissue irritants and potential sensitizers: isolate, avoid gingiva and mucosa, and do not over-wet.
If calcium hydroxide: apply a suspension to the dentin surface before provisionalization; it performs equivalently to the dentin primer for sensitivity in the 30-month crown-preparation RCT.
Why sealing works. A full-crown preparation exposes roughly 1–2 million tubules (30,000–40,000 per mm²), and hydrodynamic fluid movement through them drives the pain, so every effective step occludes or seals tubules. A 2025 meta-analysis found IDS lowered both the intensity and incidence of postoperative sensitivity, with restoration survival of 96.4–100% reported.
Seal the provisional (well-adapted margins; avoid washout of provisional cement) and verify occlusion; leakage under a poor provisional is a leading avoidable cause of persistent sensitivity.
If sensitivity persists, add fluoride varnish (calcium-fluoride deposits, relief within about 2 weeks but temporary, may need reapplication), a bioactive-glass agent (more durable occlusion, sustained to 6 months in one trial) or laser; a split-mouth RCT found diode laser and glutaraldehyde/HEMA similarly effective. Use a well-sealed provisional with soothing temporary cement as the baseline measure.
Reassess at 1 and 2–4 weeks. Escalate per the pulpal status protocol if symptoms linger, are spontaneous, or worsen.
Cautions and limits
IDS advantage for sensitivity is confined to approximately the first week (RR 0.41, 95% CI 0.27–0.60); no significant difference at 1 and 6 months. The decision should rest on the luting strategy, not on sensitivity prevention alone.
Calcium hydroxide: 6.4% of treated abutments in the 30-month RCT lost vitality to irreversible pulpitis, consistent with reported pulp-death rates after crowning; this is not specific to the material.
Much IDS bond-strength and survival evidence is in vitro or from small RCTs.
When the crown will be adhesively cemented, the resin luting system itself seals tubules; a separate desensitizer may be unnecessary.
Evidence summary
In a 36-patient split-mouth RCT (30-month follow-up), calcium hydroxide and a glutaraldehyde/HEMA dentin primer both significantly reduced sensitivity of crown abutments, with larger reduction at 7 days than immediately and no difference between agents. A 2026 meta-analysis of vital teeth prepared for fixed prostheses found glutaraldehyde/HEMA reduces hypersensitivity without significantly altering cement bond strength (MD 0.42; 95% CI −0.32 to 1.15). A pooled IDS review reported higher restoration survival (96.4–100% vs 81.8–96.7%) and fewer complications than no sealing, and reduced early postoperative sensitivity.
Glutaraldehyde/HEMA desensitizer under an IDS adhesive: bond-strength compatibility
Scope: Whether and how a glutaraldehyde/HEMA desensitizer can be combined with immediate dentin sealing without compromising resin-cement bond.
Use when
IDS protocols where additional desensitizing, antibacterial, and collagen-stabilizing effect is wanted.
Luting with self-adhesive cement or a modern universal / self-etch adhesive system.
Protocol
Apply the glutaraldehyde/HEMA agent as a thin layer on fresh dentin; observe the recommended dwell time.
Gently air-dry or blot to a glossy, non-pooled surface so no excess resin film remains.
Place the IDS adhesive over it (filled bonding resin ± flowable resin) and light-cure it separately. Do not rely on the desensitizer alone as the bonding substrate.
Match products: confirm compatibility of the desensitizer with the adhesive and the final luting cement.
Cautions and limits
Excess unpolymerized desensitizer residue can block interaction of some self-etching luting systems with dentin and reduce bond strength (reported with a self-etch primer cement).
One conventional cement (Panavia 21) showed the lowest bond strength with Gluma pretreatment and a significant decline after thermocycling: avoid that combination.
A desensitizer meta-analysis found heterogeneous effects by agent; HEMA/glutaraldehyde products are variable.
Recommendation rests on in-vitro and review-level data; clinical bond durability with this sequence has not been isolated in an RCT.
Evidence summary
A 2026 systematic review of vital teeth prepared for fixed prostheses found no significant difference in bond strength with Gluma across cement types. With universal adhesives in self-etch mode, glutaraldehyde-based desensitizers applied first increased microtensile bond strength and stabilized the interface over 1 year of aging. Pretreatment with Gluma significantly increased shear bond strength of a self-adhesive cement, including after aging. Glutaraldehyde cross-links collagen, reducing degradation of the hybrid layer over 6 months.
Reversible vs. irreversible pulpitis after crown preparation: bedside discrimination and escalation
Scope: Working through post-preparation sensitivity in a recently prepped vital tooth with an intact provisional.
Use when
Patient reports sensitivity between preparation and cementation.
Pain pattern has changed (lingering, spontaneous, nocturnal, or biting pain).
Protocol
History: onset and trajectory; spontaneous/unprovoked pain; duration after cold/heat; night pain; NSAID response; pain on biting.
Cold test (most accurate sensibility test: sensitivity about 87%, specificity about 84%) plus EPT. A brief response that resolves in seconds favors reversible pulpitis; lingering response (>30 s), spontaneous or analgesic-resistant pain favors irreversible pulpitis.
Local factors: percussion and bite tenderness; provisional fit, margins, and occlusion (premature contact); exposed cervical dentin or recession.
Imaging: periapical radiograph first-line (periapical radiolucency, PDL widening, defective provisional margin). Reserve small-FOV CBCT for inconclusive findings or suspected fracture/anatomy, per ADA/AAOMR recommendations.
If reversible: refit or re-cement a well-adapted provisional, apply a dentin sealer, adjust high contacts, and reassess.
Escalate: no response to cold/EPT, lingering or spontaneous pain, percussion pain with periapical lucency, or swelling/fever → endodontic referral. Facial swelling, fever, trismus, or floor-of-mouth involvement → urgent referral.
Cautions and limits
Symptoms correlate imperfectly with histology; diagnosis rests on the whole clinical picture.
Brief stimulus-evoked pain is expected after preparation (hydrodynamic mechanism) and typically settles over days to a few weeks.
Pulpotomy has been reported as an alternative to pulpectomy for symptomatic irreversible pulpitis in mature teeth in retrospective data; case selection matters.
Evidence summary
Post-preparation sensitivity follows the hydrodynamic mechanism through exposed dentinal tubules and is usually reversible. Cold testing and EPT performed best among pulp tests in a meta-analysis, and a national practice-based research network study supports the use of preoperative clinical findings to identify pulp status. The ICOP classification provides diagnostic criteria for pulpitis-related orofacial pain.
Derotation of round teeth with clear aligners: attachments, IPR timing, and staging
Scope: Planning rotation of canines and premolars with aligners.
Use when
Rotated canines/premolars in aligner cases, where rotation is the least predictable movement.
Protocol
Attachments: prefer manufacturer-optimized rotation attachments where available (lower mandibular canine rotation efficacy 81.5% weekly / 76.5% biweekly vs 63.1% with vertical rectangular on biweekly). For conventional composite attachments consider oblique or horizontal crescent over vertical rectangular (maxillary canines >10°: about 55% vertical, 62% horizontal, 65% oblique; overall ANOVA p=0.09).
Staging: keep per-aligner activation small; a finite-element model of a rotated lower second premolar supported no more than about 1.2° per step for round teeth (3° produced non-physiologic PDL stress).
IPR: stage IPR to coincide with the rotation steps rather than front-loading all of it, preserving an interproximal contact to act as the rotational pivot.
Execution: verify IPR with a gauge (burs/motor-driven preferred over hand strips on canines); consider partial alignment before stripping tight contacts.
Overcorrection and refinement: plan overcorrection and a refinement phase; canine derotation is typically expressed at about 50–75%.
Cautions and limits
Concurrent IPR improved canine rotation accuracy from about 36% to 43% in one synthesis, but the original prospective study (53 canines, mean accuracy 35.8%) found no significant difference among attachments-only, IPR-only, and neither groups.
A 461-tooth retrospective study found derotation predictability governed by planned rotation magnitude, available space, direction, elastics, and crown ratio, not by attachment type.
Dual (buccal + lingual) attachments improve the couple but increase PDL strain in FEA.
Executed IPR consistently falls short of planned, especially on lower canines; about 40% of prescribed IPR sites occur in refinement plans.
Evidence summary
No system has demonstrated superiority for rotation, extrusion, or torque in head-to-head trials; predictability depends on movement type, auxiliaries, and planning. Evidence on IPR timing is minimal and rests on one prospective study, retrospective cohorts, FEA, and reviews.
Interproximal reduction: per-surface and per-arch limits, finishing, and enamel protection
Scope: Planning and executing IPR within conventional enamel-thickness limits.
Use when
Space creation for crowding, rotation, or contact reshaping in aligner or fixed treatment.
Protocol
Plan from the digital setup; stay within about 50% of local proximal enamel thickness (guideline, not a validated threshold).
Commonly cited maxima per surface: upper incisors 0.3 mm, lower incisors 0.2 mm, canines 0.3 mm, premolars 0.3 mm, molars 0.4 mm. Older protocols differ (Sheridan: about 0.25 mm anterior, up to 0.8 mm per posterior surface; Tuverson: 0.3 mm per lower incisor surface, 0.4 mm canines).
Per-arch capacity at 50% across the buccal segments: about 6.8 mm maxilla, 6.0 mm mandible (mesial of first molar to first molar); anterior segment about 2–3 mm. Median prescribed in initial Invisalign plans is about 1.1 mm per patient, concentrated in the mandibular anterior.
Use a measuring gauge and protective wire; favor the thicker distal enamel; avoid small or hypersensitive teeth.
Polish sequentially to below 0.2 µm roughness (oscillating metallic strips gave the smoothest finish in vitro).
Apply fluoride varnish or another remineralizing agent; CPP-ACP, calcium-silicate products, and resin infiltration have in-vitro benefit.
Cautions and limits
Surface layer (aprismatic, mineral-rich) is removed; roughness above about 0.2 µm increases plaque retention.
Caries evidence is mixed and largely in vitro; periodontal effects arise indirectly via plaque retention. A CBCT study found no significant effect of IPR on interradicular bone volume.
Over-reduction creates irreversible furrows and dentin hypersensitivity.
Evidence summary
Reported limits derive from minimal-enamel-thickness reference data. Evidence on caries outcomes is largely in vitro with mixed results; IPR within about 50% of enamel thickness has not been shown to compromise periodontal health.
Closing open gingival embrasures (black triangles): IPR with space closure vs. direct composite
Scope: Selecting and executing conservative closure of an open gingival embrasure in a periodontally healthy patient.
Use when
IPR + orthodontic space closure: triangular crowns or diverging roots with intact interdental bone.
Direct composite: orthodontics undesired and defect driven by tooth form / contact position rather than root divergence; also to complete fill after IPR and space closure.
Protocol
Control etiology and inflammation first; treat periodontitis and correct traumatic interdental hygiene.
Measure BC–CP (anesthetize, sound to the crest with a rubber stop). Plan the apical-most contact at about 4–5 mm from the crest (papilla present in 98% of cases at ≤5 mm, 56% at 6 mm, 27% at 7 mm).
IPR route: reduce about 0.5–0.75 mm per involved mesial surface with a medium diamond strip to flatten the triangular proximal surface; close the space orthodontically; consider root paralleling when roots diverge.
Composite route: diagnostic wax-up and silicone index; isolation (rubber dam, or retraction cord with Teflon tape) to expose the subgingival contact area; 37% phosphoric acid etch on sound enamel (15–30 s), adhesive, incremental build-up lowering and lengthening the contact; consider a sectional matrix system to control proximal contour and contact position.
Use papilla compression as a guide: mild blanching acceptable, avoid sustained ischemia or trauma.
Narrow the tooth visually (move labial line angles inward; open labial embrasures) and polish; verify the emergence profile is flossable.
Cautions and limits
Esthetic ceiling: contact extended more than about 1.5 mm beyond normal, or width-to-length ratio of 0.87 or greater, looks unnatural.
Papilla lost to crestal bone destruction cannot be resurrected by IPR or resin: consider regenerative or soft-tissue augmentation or prosthetic masking after periodontal control.
Proximal composite build-ups are less durable than full coverage but conservative, reversible, and repairable (4-year clinical evaluation of direct composite additions for space closure supports their use).
Finish stripped surfaces to below 0.2 µm roughness and apply remineralizing agents, as with any IPR.
Evidence summary
Recommendations derive mainly from review articles, a case report with commentary, and a 4-year clinical evaluation of direct composite build-ups; there is no head-to-head randomized comparison of IPR with space closure vs direct composite for black triangles.
Direct composite diastema closure: preventing a black triangle
Scope: Technique for closing a midline or anterior diastema with direct composite so the new contact is carried apically and the papilla is supported, rather than leaving an open gingival embrasure.
Use when
Periodontally healthy patient with a diastema where the papilla is intact and the restorations will be bonded to sound enamel.
Contact point can be lengthened apically to within about 5 mm of the bone crest.
Protocol
Confirm periodontal health. Measure or estimate the distance from the planned contact to the alveolar crest and aim to bring the contact within about 5 mm (papilla fills the space nearly always at 5 mm or less; predictability falls as the distance increases).
Plan proportions with a diagnostic wax-up and silicone index; check width-to-length so the closed space does not over-widen the incisors.
Gain cervical access: rubber dam or retraction displaces the gingiva so composite can be placed in the zone the tissue occupied. Some clinicians prefer cotton-roll isolation to keep the papilla visible; in either case the margin should sit slightly below the gingival crest.
Matrix: contour a clear polyester strip so its gingival edge extends below the free gingival margin. Protect the adjacent tooth with Teflon tape. Avoid wedges; they lift the matrix and leave an open cervical space under the contact.
Build from the gingival and palatal aspects first, using the index or an injection template, to create a smooth convex emergence profile; then close facially. A thick putty or light-body PVS index that acts as a physical stop limits overfilling and protects tooth width.
Lengthen the contact apically with the cervical increment; mild papilla blanching is an acceptable guide, sustained ischemia is not.
Use a nanofilled or supra-nano composite in the emergence and layering zone for contour hold and polish; flowable composite is acceptable with an injection technique, with interproximal isolation so it does not polymerize onto neighboring teeth.
If full closure would over-widen the incisors, open the facial embrasures and keep the flat reflective surface narrow (optical narrowing) while still extending the contact cervically.
Finish and polish the proximal and cervical surfaces with descending-grit strips and silicone polishers; confirm the emergence is smooth and flossable.
Cautions and limits
If the contact-to-crest distance remains above about 5 mm, a black triangle may persist despite perfect technique; counsel the patient beforehand.
Wedged, flat-profile matrices are the classic cause of an iatrogenic cervical gap.
Overcontoured or rough subgingival composite promotes plaque retention and papilla inflammation.
Rubber dam vs. cotton-roll isolation is a clinician preference with no head-to-head data.
Evidence summary
Evidence is mainly case reports, technique descriptions and short-term clinical evaluations (up to 4 years) of direct diastema closure; no randomized comparison of matrix or isolation methods for black triangle prevention.
Diastema: diagnosis and choosing a closure approach
Scope: Etiology-based work-up and selection among orthodontic, restorative, frenal and periodontal/prosthetic management of a midline or anterior diastema (space of 0.5 mm or more, most often between the maxillary central incisors).
Use when
Any patient presenting with anterior spacing, before choosing between orthodontics, bonding, veneers or surgery.
Mixed-dentition patients: most midline diastemas are a normal developmental (“ugly duckling”) stage.
Protocol
History, clinical and radiographic exam. Record diastema size, crown length-to-width proportions, occlusion and anterior guidance, wear, oral habits, and the labial frenum attachment.
Identify the cause: frenum attachment, tooth-size or arch discrepancy, habits, pathologic migration, missing or undersized lateral incisors, or periodontal disease. The cause determines the treatment.
Perform tooth-size (Bolton) analysis. Generalized spacing or an interarch discrepancy usually means orthodontics and/or recontouring rather than bonding alone.
Mixed dentition: defer active treatment and reassess after canine eruption unless the diastema is very large.
Control active disease (periodontitis, gingival inflammation) before any closure.
Select the approach. Orthodontics (fixed, sectional or aligners): tooth/arch discrepancy, generalized spacing, tilted incisors, larger or multiple spaces; plan retention. Direct composite: small to moderate space, good enamel, minimally invasive single visit. Veneers (sectional or full): when shape or color must change as well; sectional veneers preserve more enamel. Frenectomy: only when an abnormal frenum contributes, ideally combined with orthodontics and performed after orthodontic closure. Periodontal/prosthetic: recession, inadequate keratinized tissue, pathologic migration; may need grafting and a resin-bonded bridge.
Plan with a smile analysis and diagnostic wax-up or mock-up to set ideal proportions and avoid over-contouring and black triangles.
For a space larger than roughly 2–3 mm, or when closure alone would make the teeth disproportionately wide, close part of the space orthodontically first, then finish with restorative recontouring.
Direct composite: shade selection, isolation, minimal or no enamel preparation, incremental layering bonded to mesial and distal enamel, careful emergence-profile contouring, finishing and polishing. See the protocol on preventing a black triangle during diastema closure.
Retain: relapse is a recognized problem, especially at the midline; provide retention after orthodontic closure.
Cautions and limits
Frenectomy alone is unpredictable; closure is far more reliable with concomitant orthodontics.
Orthodontic movement is usually deferred until the permanent canines erupt (earlier only for very large diastemas).
Composite closure is technique-sensitive; shade mismatch and chipping can occur but are generally repairable.
Closing the full space restoratively can produce disproportionately wide teeth or a black triangle; plan proportions first.
Evidence summary
Support is mainly reviews, clinical reports, case series and short-term clinical evaluations (up to 4 years) of direct composite and sectional veneer closure, plus a frenectomy outcome study; no randomized comparison of orthodontic, restorative and surgical strategies.
Last updated 2026-10-10.
Sources
Diastema — Boushell LW, Journal of Esthetic and Restorative Dentistry (2009)
Retention after orthodontic closure of a midline diastema
Scope: Retainer selection, wear schedule and relapse-risk management after orthodontic closure of a maxillary midline diastema.
Use when
Any orthodontic closure of a maxillary midline diastema; this is one of the most relapse-prone corrections.
Protocol
Address the cause before or during closure; residual etiology drives relapse (for example, an abnormal frenum, a missing or small lateral, or a habit).
Assess relapse risk at the outset: larger pretreatment diastema and a positive family history are the strongest predictors; a large space warrants more aggressive, permanent retention.
Avoid leaving residual incisor proclination (the post-treatment change most associated with reopening) and finish with good interincisal contact.
First choice: a bonded wire on the palatal surfaces of the maxillary central incisors, which provides compliance-independent, indefinite retention. In a long-term series these lasted a mean of about 17 years with roughly 2% yearly breakage and no measurable periodontal harm to the central incisors.
Optional adjunct: a vacuum-formed (or Hawley) removable retainer in addition to the bonded wire for added security. If used alone, prescribe full-time wear for about 4–6 months, then night-time wear long-term.
If an abnormal frenum is genuinely implicated, perform frenectomy after orthodontic closure, not before. Fiberotomy or excision of compressed interdental tissue is sometimes added; supra-alveolar fiber remodeling continues beyond 4–6 months, so retain for more than 12 months.
Recall periodically to check the bonded wire for debonding or breakage and for unwanted movement such as torque change or the “X-effect,” which is more frequent with maxillary bonded retainers.
Consent: document that retention is effectively lifelong and that relapse can occur even with good compliance.
Cautions and limits
Reported relapse approaches about 49% when any measurable reopening is counted; patients should hear this before treatment.
Retainers worn only 1–2 years carry long-term relapse risk.
An unnoticed debonded wire is a common route to relapse; the patient needs to report it promptly.
Do not rely on a single retainer type: no high-quality evidence defines the ideal type or duration.
Evidence summary
Minimal. Recommendations draw on diastema-specific follow-up studies and case series (bonded retainer longevity, relapse incidence, predictors), a Cochrane review that found no clear stability difference between full-time and part-time removable wear, and survey data on practice patterns. There is no randomized comparison of retention regimens specifically for diastema closure.
Scope: Hierarchical esthetic diagnosis from face to smile frame to individual teeth and gingiva, with standardized records, before any esthetic or restorative treatment is planned.
Use when
Planning veneers, bonding, diastema closure, crown lengthening, orthodontics or any smile makeover.
Establishing a reproducible baseline for pre/post comparison.
Protocol
Records. Capture a reproducible photo and video series: full face at rest and smiling, close-up smile frame, and retracted intraoral views, ideally with a millimeter reference on the gingiva. Dynamic video lets you capture the fullest smile frame by frame; it shows more gingival display than a static posed image.
Macroesthetics (face). Assess facial symmetry, vertical proportions, facial and dental midlines, interpupillary line as the horizontal reference, profile, lip fullness and nasolabial angle. Reference any occlusal cant or midline deviation to these landmarks. Plan face first: set central incisor position and length relative to the face and lips, then work outward.
Miniesthetics (smile frame). Evaluate: tooth display at rest (about 1–4 mm of central incisor; more in younger women, less in older men); smile line and gingival display (excessive display is generally judged unattractive); smile arc (incisal curve parallel to the lower lip is most attractive, inverted least); buccal corridors (minimal preferred); smile index and side-to-side symmetry; incisal edge position relative to the lower lip, verified with “f” and “v” sounds.
Microesthetics (teeth and gingiva). Central incisor width-to-length ratio (roughly 75–80%; ratios above about 85% look short and square); tooth-to-tooth proportions (lateral about two-thirds of the central width, canine about four-fifths of the lateral; the golden proportion is generally not preferred); gingival margin levels (centrals level with canines, laterals about 1 mm more coronal), zenith positions, papilla height, symmetry, color, recession and black triangles; tooth shape, color, alignment, contacts, embrasures and surface texture.
Note interactions: closing a diastema widens teeth and raises the width-to-length ratio, which may call for crown lengthening or a combined approach.
Document with a standardized instrument (for example the Smile Esthetic Index, the Dental Esthetic Screening Index, or a pictorial smile chart) so pre- and post-treatment findings are comparable.
Use a digital smile design or mock-up to preview the facially driven plan with the patient before irreversible steps.
Cautions and limits
Numeric norms are population averages from perception studies; individual and patient-preferred results vary, and professional and lay preferences differ.
Posed static photos understate dynamic gingival display and smile asymmetry.
Evaluate the smile with the patient, not only on images: confirm what they perceive as the concern.
Evidence summary
Mostly perception studies, observational studies, reviews and opinion pieces; numeric ranges vary between studies and populations. Digital smile design accuracy studies are recent and small.
Measuring tooth and gingival display at rest and in smile
Scope: Standardized capture and measurement of maxillary incisor display at rest and gingival display at full smile, with reference values and differential diagnosis when display is abnormal.
Use when
Setting incisal edge position and length before restorative or orthodontic treatment.
Evaluating a gummy smile or a lack of tooth display, and choosing between orthodontics, crown lengthening, lip repositioning, botulinum toxin or orthognathic surgery.
Protocol
Capture dynamically. Use standardized video rather than only posed photographs, then select the maximal-display frame. Posed smiles underestimate lip dynamics; spontaneous smiles show more gingiva.
Position: natural head position, camera lens at the level of the maxillary incisal edge, with a calibrated reference (for example facial-reference glasses with known-distance targets) to set the scale.
Record three positions: (1) lips in repose (patient says “Emma” and lets the lips part slightly) for minimum tooth display; (2) maximum display (patient shows the gums and smiles fully, with eye-squint, to obtain the Duchenne smile) for maximum lip dynamics; (3) a social smile.
Measure vertically: incisal edge to lower border of the upper lip at rest; free gingival margin of the central incisor to the lower border of the upper lip at full smile. Use digital calipers on calibrated images or directly in the mouth.
Compare with reference values. At rest, central incisor display is about 1–4 mm (about 3 mm in a younger woman; 1 mm or less in an older man; none is common with incisal wear). At full smile, about 1–2 mm of gingiva is typical; 3–4 mm or more is generally classed as a gummy smile, but tolerance varies (clinicians accept less than laypeople).
Classify lip form at rest (straight 0–3 mm, moderate more than 3–6 mm, high more than 6 mm, by the height difference between the most superior vermilion and the commissure vermilion) and smile line (high, average, low).
Use the canine tip relative to the upper lip at rest as an additional landmark; it is less variable than the central incisor.
If display is abnormal, separate causes using clinical and cephalometric variables (upper lip length and elevation, interlabial gap, anterior maxillary height, occlusal plane angle): soft tissue (short or hyperactive lip), skeletal (vertical maxillary excess) or dentogingival (altered passive eruption). Direct treatment accordingly.
Record the measurements and frames in the chart for pre/post comparison.
Cautions and limits
Values are reference ranges, not targets: display depends on lip length, curvature, tone, age and sex.
Display declines with age; maximal incisor display in smile or speech is similar from the teens through the 30s and falls significantly after about 40.
Sex differences in display reflect lip dynamics and facial proportion; the width-to-length ratio of the central incisor does not differ by sex, though absolute tooth size is somewhat larger in men.
A single static photograph can mislead: confirm findings on video.
Evidence summary
Reference values derive from cross-sectional and observational studies, a meta-analysis of incisor dimensions, and clinical protocols from expert authors; populations and methods differ, so ranges vary between studies.
Scope: Diagnosing the cause of excessive gingival display (more than about 3–4 mm of gingiva on smile) and selecting treatment accordingly.
Use when
Patient presents with excessive gingival display, or a smile analysis shows gingival display beyond the patient's or clinician's tolerance.
Planning anterior restorative or orthodontic treatment where gingival display affects the result.
Protocol
Measure display at rest and in smile on video (see the protocol on measuring tooth and gingival display). Record upper lip length and mobility, passive eruption status (CEJ-to-bone distance on sounding), incisor position and wear, and maxillary vertical height.
Identify the cause or causes. The most common presentation is a hypermobile upper lip combined with altered passive eruption (about 45% of patients in one series), so look for coexisting causes.
Altered passive eruption: esthetic crown lengthening (gingivectomy, or apically positioned flap with osseous resection when the bone crest is near the CEJ). Preserve about 3 mm from CEJ to bone for supracrestal attachment; allow 3.5–4 mm in thin phenotypes to offset rebound.
Hypermobile upper lip: botulinum toxin A as the first non-surgical option (targets such as the levator labii superioris alaeque nasi, levator labii superioris, zygomaticus minor, or the “Yonsei point”; reported doses of roughly 1.25–7.5 U per side; display reduced by about 2.5 mm, peak effect at 2–4 weeks, lasting about 12–24 weeks, so maintenance is needed). Lip repositioning surgery lasts longer. Four-point injection schemes have outperformed two-point schemes.
Short or hypotonic lip: lip lift for a truly short lip; hyaluronic acid lip augmentation for volume and contour.
Dentoalveolar extrusion or incisor supraeruption (often Class II division 2 or worn teeth): orthodontic intrusion, often with miniscrews. Prefer an ortho-restorative approach over crown lengthening for worn, supraerupted teeth.
Vertical maxillary excess: Le Fort I impaction is definitive for severe cases. Lip repositioning is a less invasive option for mild (about 2–4 mm) to moderate (about 4–8 mm) excess.
Multifactorial or severe, surgery declined: combination therapy (crown lengthening, botulinum toxin and hyaluronic acid lip augmentation). One 18-month case series reported display falling from 4–9 mm to about 1.5 mm.
Select by severity, number of causes, the invasiveness the patient will accept, and the durability required. Use minimally invasive options (toxin, hyaluronic acid, orthodontic intrusion) for milder cases and orthognathic surgery for true skeletal excess.
Gummy smile: match the treatment to the cause.
Cautions and limits
Botulinum toxin is not indicated when the sole cause is altered passive eruption, gingival thickening or incisor supraeruption; display above about 5 mm may not reach the cosmetic threshold with toxin alone.
Lip repositioning shows partial relapse (about 25% by 12 months or later); pre-operative toxin, spacers or combined crown lengthening may improve stability.
Using one technique for every patient fails; the cause determines the treatment.
Orthodontic intrusion with miniscrews is supported mainly by finite-element and review data; plan root and anchorage safety.
Tolerance varies: orthodontists tend to find more than 2 mm of display unattractive while laypeople often accept up to about 4 mm.
Evidence summary
Botulinum toxin has the strongest support (randomized trials, systematic reviews and meta-analysis). Crown lengthening and lip repositioning are supported by reviews and a clinical study showing improved smile attractiveness. Combination therapy rests on a recent case series; orthodontic intrusion rests on a systematic review and finite-element data. There is no head-to-head randomized comparison of all options.
Esthetic crown lengthening for altered passive eruption: technique and biologic width
Scope: Diagnosis, subtype-based technique selection, open-flap surgical sequence and biologic width targets for esthetic crown lengthening in altered passive eruption (APE).
Use when
Excessive gingival display with short clinical crowns where APE is the cause (see the protocol on gummy smile by etiology).
A healthy, non-inflamed periodontium after phase I therapy.
Protocol
Diagnose and subtype. Use transgingival bone sounding to find the crest-to-CEJ relationship, and assess keratinized tissue width, incisal edge position, CEJ location and lip line at rest and in smile. Type 1 has wide keratinized tissue and Type 2 normal; subgroup A has the crest about 1.5 mm apical to the CEJ and subgroup B has the crest at the CEJ.
Select the technique. Type 1A: gingivectomy alone. Type 1B (the most common): flap with ostectomy. Type 2A: apically positioned flap. Type 2B: apically positioned flap with osseous resection. Flapless surgery gave comparable 12-month results with less postoperative pain and swelling, but is technique-sensitive, limits visualization of bone removal and is unsuitable for Type 2B.
Prepare. Complete phase I therapy (scaling, hygiene instruction) and resolve inflammation about one week before surgery. Plan the new margin from a facially driven wax-up or digital smile design, with a central incisor width-to-length ratio of about 75–85% and planned zenith positions. Make a surgical guide; CBCT-based double-guide workflows can transfer both the gingivectomy line and the bone level.
Anesthesia and marking. Infiltrate buccally and palatally; use the guide or a periodontal probe to mark bleeding points for the new margin.
Internal bevel incision. Make a scalloped submarginal incision with a #15c blade, following CEJ anatomy from mesial to distal line angles and preserving the papillae. Extend as needed (often premolar to premolar).
Sulcular incision and collar removal. Free and excise the marginal gingival collar.
Flap. Elevate a full-thickness mucoperiosteal flap buccally to expose the CEJ and crest, without releasing beyond the mucogingival junction.
Ostectomy. Where the crest is less than about 3 mm from the CEJ, remove bone with a round bur, chisels or piezo under irrigation to reach the target crest-to-CEJ distance. Limit resection to the buccal aspect and preserve interproximal bone.
Osteoplasty. Recontour thick or irregular buccal bone to a festooned architecture matching the planned scallop.
Reposition and suture. Replace the flap with the margin about 3 mm coronal to the new crest; close with interrupted or vertical mattress sutures (for example 5-0 polypropylene).
After care. Chlorhexidine rinse, suture removal at about 7 days, and reviews at 6 weeks and again at 3–12 months for maturation.
Biologic width targets. Classic mean dimensions are sulcus 0.69 mm, junctional epithelium 0.97 mm and connective tissue attachment 1.07 mm (about 2.04 mm attachment, about 2.73 mm supra-osseous soft tissue). Commonly cited targets are about 3 mm from crest to CEJ or restorative margin; some protocols leave 2–2.5 mm of crest-to-CEJ distance and aim for about 3 mm of supracrestal attachment. These targets differ between protocols; do not average them.
Individualize. Biologic width varies widely between patients (reported 2.67–5.00 mm), so measure the patient's own supra-osseous gingiva by bone sounding.
Plan for rebound. Thick phenotypes show more coronal regrowth; consider about 3.5–4 mm of bone reduction and be prepared for secondary refinement. Some creep (about 0.4–0.45 mm) is expected over 12 months even with correct technique.
Cautions and limits
Over-resection in the esthetic zone risks black triangles, flattened papillae and long clinical crowns; keep ostectomy buccal and preserve interproximal bone.
Operating on an inflamed periodontium, or leaving less than about 3 mm of crest-to-margin tissue in a thick phenotype, predicts rebound.
Gingivectomy alone is appropriate only when the crest is at least about 1.5 mm apical to the CEJ (Type 1A).
Numeric biologic width targets are not uniform across the literature.
Evidence summary
Support includes randomized trials of flap and flapless approaches, guided planning and diode laser use, prospective and 12-month stability studies, a systematic review of adjacent-site effects and narrative reviews; most trials are small. Two cited conference-poster abstracts in the source dossier were not included here because they had no verifiable titles.
Gingival margin rebound and stability after esthetic crown lengthening
Scope: Predicting and managing coronal rebound of the gingival margin after esthetic crown lengthening (ECL), including timing of definitive restorations and long-term stability.
Use when
Planning bone resection and flap position for ECL (see the protocol on technique and biologic width).
Deciding when to take final margin measurements or place definitive restorations after ECL.
Counseling patients on expected margin position and thick versus thin phenotype.
Protocol
Set the margin-to-crest distance. The main controllable determinant of rebound is the post-surgical distance from gingival margin to alveolar crest (GM-AC). Suture the flap with the margin about 3 mm coronal to the crest.
Know the expected rebound by GM-AC (6-month data): 1 mm or less, about 1.3–1.4 mm; 2 mm or less, about 0.9 mm; 3 mm, about 0.1–0.5 mm; 4 mm or more, net recession of about 0.15–0.26 mm rather than rebound.
Remove bone, not just soft tissue. Base the plan on the restorative and esthetic target plus the patient's own supracrestal tissue dimension. In the sources reviewed, margins were stable from 3 months when at least 3 mm of bone was removed; length gained mainly by soft-tissue excision and apical flap positioning with about 1 mm of bone removal rebounded by roughly 3 mm, and about half of teeth ended shorter than planned.
Adjust for phenotype. Thick, flat phenotypes rebound about twice as much as thin, scalloped ones (about 0.37 mm thin versus 0.70 mm thick at 6 months; about 0.5 mm more at 1 year in one study). Plan greater ostectomy in thick phenotypes rather than a uniform 3 mm cut.
Respect the time course. Most rebound occurs within 3 months and plateaus; change between 3 and 6 months was only about 0.12–0.15 mm. A 12-month study found stable margins at 3, 6 and 12 months. Take final measurements and place definitive restorations after about 3–6 months of maturation.
Consider long-term thickness. In a longitudinal analysis of six randomized trials, gingival thickness of about 1.5 mm or more at 6 months (with at least 1.5 mm of keratinized tissue) was associated with less than 0.5 mm of recession over 10 years; thickening thin sites gave the largest benefit.
Review. Recall at 3 and 6 months to confirm margin position before restorative work, and again at 12 months.
Cautions and limits
One randomized comparison of conventional versus digital planning found no correlation between margin stability and gingival thickness, so phenotype effects are not uniform across studies.
Early margin stabilization approaches (such as the GingivalStat technique in the first 15 days) rest on a small case series; evidence on the first two postoperative weeks is limited.
Margin position established correctly appeared stable for more than 15 years in one long-term series, but it is a single-author series.
Do not place definitive margins on a margin that is still maturing.
Evidence summary
Evidence comes from prospective clinical studies, a systematic review of pre-restorative crown lengthening, a 12-month clinical study, a long-term (over 15 years) series, a pooled analysis of six randomized trials on thickness, and a small case series. Magnitudes vary across studies, and the numeric figures above are quoted as reported in them.
Timing of definitive restorations after crown lengthening
Scope: How long to wait, and how to manage provisionals, before final preparation and definitive restorations after crown lengthening surgery.
Use when
Any crown lengthening followed by indirect restorations (crowns or veneers), especially in the esthetic zone.
Protocol
Identify how the length was gained. Waiting time depends on whether crown length came from adequate bone removal or mainly from soft-tissue resection and apical flap positioning.
Soft-tissue-only gingivectomy: about 6 weeks before definitive restoration.
Open-flap ostectomy and osteoplasty with adequate bone removal: wait at least 3 months; the free gingival margin is stable from about 3 months when bone was removed to match the restorative target plus the preoperative supracrestal tissue dimension.
Esthetically critical zone or several anterior teeth: allow 3–6 months for soft-tissue maturation, biologic width re-formation and final architecture.
Length gained mainly by soft-tissue resection or with inadequate ostectomy: expect prolonged rebound; delay final preparation to 9–12 months and confirm stability first.
Manage the interim with provisionals. Option A, early preparation (about 3 weeks): keep provisional margins at the presurgical level for the first 3 weeks, then prepare at or near gingival level with a knife-edge margin using the healed margin as a guide, and reline the provisional; definitive restoration still follows soft-tissue stabilization. Option B, delayed preparation: keep provisional margins at the presurgical level until stability is confirmed at 9–12 months, then complete final preparation and delivery.
Confirm before the final impression. Verify that the margin has reached the planned position, ideally within about 0.5 mm of the mock-up or planned level.
Do not place a margin into immature tissue. A shallow or absent sulcus in proliferating tissue invades the biologic width.
Cautions and limits
Time alone does not guarantee stability; the flap-to-crest position at suturing (about 3 mm) governs the result.
Rebound time course in one randomized study: about 60% of coronal migration in the first month, about 80% by 3 months, about 90% by 6 months, with minimal change from 6 to 12 months.
Early preparation protocols come mainly from a review article and expert guideline; they are not tested head-to-head against waiting.
Multiple adjacent teeth and thick phenotypes favor the longer end of the range.
Evidence summary
Moderate to limited. Support includes a randomized trial comparing one- and two-stage crown lengthening (final restorations at 6–9 months with margins within 0.5 mm of plan in 80% of patients), a randomized time-course study, prospective stability data, and review and guideline articles. The specific interim provisional schedules rest on narrative reviews and expert guidance.
Provisional restoration margin management during crown lengthening healing
Scope: Managing provisional margins, contacts and relining after crown lengthening so the provisional does not impinge on the re-forming supracrestal attachment.
Use when
Crown lengthening in teeth that will receive crowns or veneers and need a provisional during healing.
Choosing between intra-operative, early (3-week) and delayed abutment preparation (see the protocol on timing of definitive restorations).
Protocol
General rule. Keep provisional margins at or coronal to the presurgical gingival level and at least 1 mm away from the soft tissue during healing. Never place them into the immature sulcus; refine them progressively as the tissue matures.
Option 1, intra-operative preparation and relining. Prepare the abutments during surgery after ostectomy and osteoplasty, with knife-edge margins, and reline the provisional at suturing. Hold prosthetic margins at least 1 mm from the gingival level and monitor them; modify the provisional as often as the expected rebound dictates (flap position at suturing and biotype). Deliver the final prosthesis once soft-tissue stability is observed.
Option 2, early (3-week) preparation and relining. Leave the presurgical provisional untouched for 3 weeks while initial healing and connective-tissue reattachment occur (about 1 mm of peri-dental bone resorbs). At 3 weeks probing depth is zero and sulcus and papillae are still absent, so future subgingival tooth structure is still supragingival: prepare at or near gingival level with a knife-edge margin, guided by the healed soft-tissue margin, and reline a new provisional at the same level. Reported advantages: less aggressive preparation, no biologic-width interference, easy supragingival relining without retraction cord, and soft-tissue conditioning during peak regrowth.
Option 3, delayed preparation. Hold the provisional margins at the presurgical level until soft-tissue stability (9–12 months), then complete final preparation and the definitive prosthesis. This best avoids interfering with healing but prolongs the interim phase.
Manage the interdental aspect. After early preparation, modify the provisional only interproximally. Set the contact point initially about 3 mm from the interdental soft tissue and shift it coronally about 1 mm at a time as the papilla fills in, increasing interproximal convergence progressively to encourage papillary growth. Take the final impression only when the papillae show no further growth relative to the last contact position.
Margin depth in the healed sulcus. With a sulcus of 1.5 mm or less, the margin may sit about 0.5 mm subgingivally; with a deeper sulcus, place it at roughly half the sulcus depth. Maintain at least 3 mm between the restorative margin and the alveolar crest.
Staged option when keratinized tissue is sufficient. Perform a gingivectomy to the anticipated margins and place a provisional at the same visit. After about 6 weeks of soft-tissue healing, perform ostectomy in a second stage using the provisional margins as the guide, and proceed to the definitive restoration about 3 months later. This avoids exposed roots, crown margins and open embrasures during healing.
Cautions and limits
Placing a margin into immature tissue with a shallow or absent sulcus violates the biologic width because the tissue is still proliferating.
The temporary violation of supracrestal tissue in the staged option is acceptable only because the re-establishment response is delayed; ostectomy must follow.
The three sequencing protocols are described in narrative review and guideline articles; they have not been compared head-to-head in a trial.
Evidence summary
Moderate to limited. Based on a comprehensive narrative review, a periodontal-restorative interface review and a staged crown lengthening classification and guideline article; no randomized comparison of the provisional management protocols.
Managing biologic width violation by an existing restoration
Scope: Diagnosing and correcting encroachment of a restoration margin on the supracrestal tissue attachment, and replacing the restoration with a correct margin.
Use when
Persistent gingival inflammation, bleeding on probing, deeper probing depths, recession or an interproximal intrabony defect adjacent to a subgingival restoration margin.
Protocol
Diagnose. Encroachment occurs when the margin extends into the junctional epithelium and connective-tissue attachment, leaving less than about 3 mm between margin and alveolar crest. The tissue response varies with phenotype: chronic inflammation in thick phenotypes, recession or bone loss in thin ones. Confirm with probing depths, margin-to-crest measurement (bone sounding) and radiographs.
Separate violation from plaque retention. Overhangs and overcontoured margins act as plaque traps, and with meticulous plaque control some subgingival margins remain healthy. Much permanent damage (recession) stems from preparation and impression trauma rather than nominal margin position. Remove the overhang or defective restoration, control inflammation, and reassess before committing to surgery.
Initial therapy. Remove the defective restoration or provisionalize with a supragingival or well-contoured margin, and scale. Crown lengthening is done only on a non-inflamed periodontium.
Choose a method by esthetics, crown-root ratio, root anatomy, defect depth and location, keratinized tissue and restorative endpoint.
Surgical crown lengthening (apically positioned flap with ostectomy) is the standard definitive approach: osseous resection re-creates at least 3 mm between new margin and crest. Drawbacks: attachment and bone loss on the treated and adjacent teeth, longer clinical crowns, black triangles and an altered crown-root ratio, which matters most in the esthetic zone.
Orthodontic extrusion moves the tooth coronally to bring sound margin above the crest without sacrificing adjacent bone, and is preferable in the anterior esthetic zone. Trade-offs: longer treatment, higher cost, more visits and relapse tendency (circumferential supracrestal fibrotomy may be needed). Extrusion reduces only the intrabony root length, so it is more favorable to the crown-root ratio than surgical lengthening.
Controlled surgical extrusion (minimally traumatic coronal repositioning) gives rapid lengthening when orthodontic extrusion is impractical.
Deep margin elevation for shallow-depth interproximal subgingival margins: an adhesive composite step raises the margin to an equigingival or supragingival level without osseous surgery. It depends on rubber dam isolation and does not substitute for crown lengthening when the margin lies within the attachment itself; poorly executed deep subgingival composite can itself provoke inflammation.
Replace the restoration. Once tissue is healthy, place the margin by sulcus depth: sulcus 1.5 mm or less, about 0.5 mm subgingival; deeper sulcus, about half the sulcus depth; always keep at least 3 mm from the alveolar crest. Prefer supragingival or minimally subgingival margins (0.5 mm or less) where esthetics permit. Eliminate overhangs and overcontour, keep the interface smooth, and enroll the patient in plaque control and periodontal maintenance.
Consider extraction when correction would excessively compromise adjacent teeth (anterior sextant) or the tooth has an unfavorable crown-root ratio, furcation involvement or inadequate ferrule after resection; replacement by implant or prosthesis may then be more rational.
Cautions and limits
Deep margin elevation is not appropriate when the margin is inside the attachment zone.
Crown lengthening removes support from adjacent teeth; in the anterior sextant this can cause recession and black triangles.
Evidence for deep margin elevation is partly survey-based and recent; long-term controlled data are limited.
A 0.5 mm subgingival margin does not interfere with the supracrestal attachment; deeper margins do carry greater inflammation and attachment-loss risk.
Evidence summary
Moderate to limited. Based on reviews of the periodontal-restorative interface, a systematic review and meta-analysis of crown lengthening effects on adjacent sites, randomized trials of margin designs and gingivectomy versus crown lengthening, an observational study of controlled surgical extrusion, an in vitro crown-root ratio study, and recent clinical and survey data on deep margin elevation. One conference-poster abstract in the source list was omitted because it had no verifiable title.
Orthodontic extrusion (forced eruption) to restore biologic width
Scope: Rate, force, fiberotomy decision and retention for orthodontic extrusion used to relocate restorative margins supragingivally or to develop tissue.
Use when
Biologic width violation, inadequate ferrule, subgingival or subcrestal fracture or caries, particularly in the esthetic zone where resective surgery would cause recession or black triangles.
Periodontal infrabony or papillary defects and implant site development (slow extrusion without fiberotomy).
Protocol
Select candidates. Confirm adequate residual root length and a favorable final crown-root ratio. Contraindications: active inflammation, ankylosis, hypercementosis, vertical root fracture and root proximity. If residual root length or crown-root ratio would be unfavorable, consider extraction and replacement.
Know the biology. Extrusion reduces only the intrabony root length and keeps crown length constant, so it preserves the crown-root ratio better than surgical lengthening (which shortens both) and keeps the gingival architecture intact. It moves plaque coronally rather than apically, so it can be used in a reduced periodontium.
Choose the goal, which sets rate and fiberotomy. To bring bone and gingiva with the tooth (implant site development, infrabony or papillary defects): slow extrusion with light force and no fiberotomy. To lengthen the clinical crown while leaving margin and bone behind (biologic width restoration or ferrule): faster extrusion with repeated circumferential supracrestal fiberotomy (CSF) to prevent the marginal tissues following the tooth.
Force and appliance. Use light, continuous extrusive force to limit root resorption, ankylosis and unwanted intrusion of anchor teeth. Fixed appliances (brackets and archwire on anchor teeth with elastics or NiTi wire) are preferred over removable ones, which depend on compliance. Multibracket extrusion is effective and, unlike surgical or magnetic extrusion, does not require prior root canal treatment of the target tooth.
Representative sequence. Control inflammation first (supragingival provisional for about 6 weeks); bond passive brackets to anchor teeth; apply a NiTi wire for about 3 months while reducing the provisional incisally or palatally to allow eruption; perform supracrestal fiberotomy to release Sharpey fibers; then hold with a passive wire for retention before removal.
Retain. Relapse is the major complication, driven by the elasticity and slow remodeling of stretched supra-alveolar fibers, which continues beyond 4–6 months. Plan retention of at least 12 months, or at least as long as the active extrusion time, before the definitive restoration.
Fiberotomy. CSF reduced relapse in a long-term prospective study (most for rotational relapse, in the maxillary anterior) without clinically significant increase in sulcus depth or loss of attached gingiva, but systematic-review-level evidence for CSF is weak, and repeated CSF can occasionally provoke osseous resorption of adjacent bone. It does not replace mechanical retention.
Prerequisites for ferrule creation on a fractured anterior tooth. Complete endodontic therapy first, because the canal and post (or a bonded attachment on the crown) anchor the extrusive force. Confirm enough remaining root length for a favorable crown-to-root ratio after extrusion (target about 0.8 or better) and plan the movement, usually 2–6 mm with means around 2–3.5 mm, so that a 2 mm dentin ferrule can be restored. Rule out ankylosis, hypercementosis, root fracture, pre-existing resorption and insufficient root length.
Active-phase appliance sequence (rapid protocol). Bond or build the attachment on the target tooth and passive brackets on one mesial and one distal anchor. Place the bracket on the extruded tooth 3–4 mm apical to the anchor brackets with no tip so the NiTi wire delivers a purely axial force (above 300 g; measured about 350–450 g), and level the brackets to reduce wire curvature if the appliance cannot hold the load. Over four weekly appointments: appliance placement with the first fiberotomy; two check visits to relieve any occlusal contact that blocks migration with the fiberotomy repeated at the first and second visits; then removal of the active appliance. Perform the fiberotomy under local anesthesia with a #15 scalpel in a circular sweep around the crown to the bone crest, followed by root planing of the sulcus to remove fiber remnants.
Fiberotomy timing is not standardized. Regimens range from a single cut before extrusion to weekly incisions; commonly cited schedules are at the start and about every 2 weeks, or weekly twice. For ferrule creation you want the fiberotomy, because without it the free gingiva follows about 90% and the attached gingiva about 80% of the movement and drags the margin coronally. Omit it when coronal tissue migration is the goal.
Simplified high-force and low-force variants. An elastic-driven variant anchors a fiber-reinforced composite extrusion pin or intracoronal elastic to a provisional cantilever or palatal bar and delivers about 5–15 N with elastics replaced about twice daily, reaching several millimeters in days (6 mm in 11 days in one report); a palatal-bar vector limits labial tipping that threatens the buccal plate. A separate concept using adhesively bonded CAD-designed attachments with forces above 50 g reported a mean extrusion of 3.5 +/- 0.9 mm over about 20 +/- 12 days to re-establish biologic width and a 2 mm ferrule.
Retention intervals reported. The bracket protocol splints the tooth to adjacent teeth for about 4–6 weeks; a recent review recommends at least 10 weeks before definitive restoration, and a pilot study averaged about 127 days. These figures differ from the 12-month retention suggested above for relapse-prone movements; choose the longer interval when the movement was large or relapse is already occurring, and re-extrude if relapse occurs before the final crown.
Expect trade-offs. Compared with surgical crown lengthening: longer treatment, more visits, higher cost, and relapse that may need repeat fiberotomy.
Cautions and limits
Excess force risks root resorption, ankylosis, or intrusion of anchor teeth.
A clinical study of forced extrusion of extensively damaged teeth reported about 94% survival over a mean of about 3.3 years, with relapse the dominant complication.
Evidence is mainly reviews, case series and small clinical studies; the CSF data are largely from a single long-term prospective study.
The slow-versus-fast and fiberotomy rules come from guidelines and narrative reviews rather than head-to-head trials.
Evidence summary
Moderate to limited. Support is from guideline and narrative reviews, a systematic review, a case series and a clinical study with health economic follow-up, an in vitro crown-root ratio study, a long-term prospective study of fiberotomy, and a systematic review that rated adjunct support (including CSF) as weak.
Choosing between orthodontic extrusion and surgical crown lengthening
Scope: Comparing orthodontic extrusion with surgical crown lengthening on periodontal outcome, crown-root ratio, esthetics, survival and cost to select an approach for teeth with biologic width violation or insufficient ferrule.
Use when
Selecting a method to gain supragingival tooth structure before restoring a tooth with a subgingival or subcrestal margin (see the protocols on orthodontic extrusion and biologic width violation).
Protocol
Favor orthodontic extrusion for anterior esthetic-zone teeth, subcrestal or subgingival defects where preserving bone and gingival symmetry is paramount, and cases needing a better crown-root ratio.
Favor surgical crown lengthening for posterior or non-esthetic sites, when rapid single-stage correction is preferred, when adjacent bone can tolerate resection, and when patient compliance or treatment duration makes orthodontics impractical.
Weigh periodontal effects. Extrusion preserves or augments supporting bone, directs plaque coronally (so it can be used in a reduced periodontium even with imperfect hygiene), tends to reduce pocket depth and widen attached gingiva, and affects adjacent teeth little. Surgical lengthening requires osseous reduction; a systematic review found attachment effects on the treated and on adjacent and non-adjacent teeth, with recession and black triangles possible.
Weigh crown-root ratio. Extrusion reduces only intrabony root length; surgical lengthening lengthens the clinical crown and reduces bony support. In one in vitro study the effective crown-root ratio was about 22% lower with extrusion at 2 mm and about 30% lower at 4 mm, compared with surgical lengthening.
Corroborating load-capability data. In a separate in vitro load-capability study, surgical crown lengthening gave the highest and least favorable crown-root ratio (clustered around 1.0, about 25% above control), while extrusion and apical root resection stayed in a more favorable 0.7–0.9 range. A crown-root ratio above 1.0 has been associated with worse survival of endodontically treated, post-restored teeth, which is why the ratio difference matters clinically, but the survival link is inferred rather than measured in a comparison of the two techniques.
Geometry behind the difference. Crown lengthening worsens the ratio twice (a longer clinical crown and less bone-supported root); extrusion changes it once (less effective root length with crown length unchanged).
Weigh esthetics. Extrusion maintains gingival architecture; surgical lengthening disturbs marginal contour and is disadvantageous in the esthetic zone.
Weigh burden and cost. Extrusion takes longer, needs more visits, costs more and has a relapse tendency requiring repeated fiberotomy. Surgical lengthening is a single, faster, generally cheaper procedure. These are qualitative judgments, not formal cost-effectiveness analyses.
Consider extraction when either approach would leave an inadequate ferrule or an unfavorable final crown-root ratio.
Cautions and limits
No randomized trial directly comparing restoration survival between the two techniques was found; the evidence is case series, narrative reviews, in vitro data and one health-economic study.
Extrusion survival figure: about 94% over a mean of about 3.3 years in one clinical study of extensively damaged teeth, with relapse the dominant complication; there is no matched comparative survival figure for surgical lengthening.
Extrusion is not free of attachment consequences: in a canine experiment, circumferential fiberotomy during extrusion did not fully prevent coronal migration of the attachment and was associated with gingival recession and connective tissue attachment loss.
Formal health-economic comparison data are largely absent.
A systematic review of forced eruption for subgingival anterior fractures judged it a feasible pre-restorative option and found root resorption not clinically relevant, but the evidence base was largely case series; the two in vitro ratio studies used extracted teeth and cannot show clinical survival.
Evidence summary
Minimal. No head-to-head randomized comparison of survival or cost. Evidence consists of narrative and systematic reviews, case series, an in vitro crown-root ratio study, a health-economic analysis of extrusion alone, and an animal experiment.
Ferrule requirements for endodontically treated anterior teeth
Scope: Dimensions of an adequate ferrule, what to do with a partial ferrule, and how to regain a ferrule before restoring an endodontically treated anterior tooth.
Use when
Planning a crown, post and core or endocrown on an endodontically treated tooth with limited coronal structure.
Protocol
Target a complete 360° ferrule of sound tooth structure apical to the core: height at least 1.5–2.0 mm and axial dentin thickness at least 1.0 mm. A meta-analysis found that a ferrule height of 2 mm or more raised fracture resistance by a mean of about 165 N, and one premolar in vitro study found resistance fell about 37% going from a 2 mm ferrule to none.
Thickness. Residual dentin of at least 1.0 mm is the practical floor; in vitro work on incisors showed resistance increasing with thickness, highest at 1.5 mm or more.
Wall form. Keep ferrule walls roughly parallel and preserve coronal wall height of at least 3 mm above the gingival margin where possible; this further improves survival independent of the ferrule.
If a complete ferrule is not achievable, an incomplete ferrule is still protective. In a systematic review of 19 in vitro studies a partial ferrule significantly increased fracture resistance compared with none; two or more opposing residual walls were most beneficial.
Do not rely on the post or core to compensate. An adequate ferrule lowers the biomechanical impact of the post and core system, cement and crown material. In anterior teeth, 2 mm ferrules withstood higher loads regardless of core type, and fiber-reinforced composite cores increased resistance and reduced catastrophic, non-repairable fractures. Posts mainly improve prognosis when substantial structure is missing (fewer than two walls, no ferrule); with an adequate ferrule and two or more walls, a post adds little.
When insufficient coronal structure remains, re-establish a ferrule before the definitive restoration rather than accepting a ferrule-free preparation, which carries a high failure rate. In the anterior esthetic zone, orthodontic extrusion is preferred over surgical crown lengthening to gain ferrule height while preserving bone and gingival architecture.
If neither method is feasible, a poor outcome is likely and extraction and replacement should be weighed.
Cautions and limits
A circumferential ferrule improved success of fiber-post-restored teeth in a direct meta-analysis (relative risk about 1.28), but the pooled indirect survival analysis was not statistically significant; evidence quality is moderate.
Numeric thresholds come mainly from in vitro fracture-resistance studies and systematic reviews of them; clinical trial support is more limited.
In the finite-element and fracture studies reviewed, a ferrule shifted peak stress deeper in the root and favored shallower, more repairable fracture patterns; failure mode matters as much as load.
Evidence summary
Moderate. Based on systematic reviews and meta-analyses (including one 2026 review of ferrule dimensions and one on circumferential ferrules with fiber posts), a systematic review of in vitro studies on incomplete ferrules, a classic literature review, and in vitro fracture and finite-element studies on premolars and anterior teeth.
Recording centric relation: sequence, techniques and materials
Scope: Sequence for recording centric relation (CR) for mounting casts, with technique categories, recording materials and reproducibility evidence.
Use when
Mounting casts for diagnosis or full-arch restorative, prosthodontic or splint therapy where a repeatable condylar reference position is needed.
Protocol
Definition. CR is the maxillomandibular relationship, independent of tooth contact, in which the condyles articulate in the anterior-superior position against the posterior slopes of the articular eminences, with the mandible restricted to pure rotation. It is a repeatable reference position for mounting casts.
Reduce splinting and deprogram. Address inflammation and muscle splinting, and deprogram the proprioceptive memory of maximal intercuspation: anterior jig (Lucia jig), leaf gauge, anterior deprogrammer, cotton rolls over the molars, or a period of biting to fatigue the elevators.
Position the patient reclined about 120° to favor condylar seating and relaxation.
Seat the condyles. Either operator-guided (bimanual manipulation, chin-point guidance, power centric) or patient-determined (Gothic arch tracing, swallowing, free closure after deprogramming). Operator-guided methods are criticized for force variability and a protective protrusive reflex if too much force is used; patient-determined methods are less likely to exceed physiologic limits.
Verify repeatability. The mandible should return to the same position on repeated hinge closures (for example, the lower incisors meeting the same jig indentations) before recording.
Record at a slightly opened vertical dimension without tooth contact, using a rigid material, then mount with a facebow transfer. Polyvinyl siloxane and polyether performed best for reproducibility and are preferred over wax for the definitive record; unrefined wax wafers with bimanual manipulation still showed strong precision and efficiency.
Digital options. Jaw-tracking devices record multiple closures against an anterior plateau; patient-reported comfort was comparable to bimanual manipulation, though conventional recording was faster.
Choose by familiarity. A best-evidence consensus found chin-point guidance, bimanual manipulation, power centric, Gothic arch tracing, leaf gauge and anterior deprogramming devices comparable in precision, with clinician experience the critical variable.
Cautions and limits
Different CR records reproduce slightly different condylar positions (median spatial differences about 0.48–0.79 mm between methods), though repeat-record variability was similar across techniques.
One digital study found higher reproducibility with a frontal deprogrammer and Gothic arch device (about 0.12 mm) than with bimanual manipulation and leaf gauge (about 0.21–0.23 mm); this is a preliminary report.
In edentulous patients, Gothic arch recordings had the best reproducibility but needed more chair time.
A systematic review found no high-level evidence that CR is a diagnostic or therapeutic gold standard; treat it as a technically useful, repeatable reference position rather than a validated physiologic ideal.
Evidence summary
Moderate to limited. Based on a best-evidence consensus statement, a biologic-perspective review, randomized and cross-over trials on muscle activity and splint recording, observational reproducibility studies, MRI work on condylar position, and preliminary digital studies.
Determining and verifying occlusal vertical dimension (OVD)
Scope: Combining methods to determine OVD for full-mouth or complete denture rehabilitation, and verifying it before definitive restorations.
Use when
Planning complete mouth rehabilitation, complete dentures, or any treatment that increases or restores OVD.
Protocol
Accept that there is no gold standard. Combine converging methods rather than relying on one measurement. The habitual rest position is unstable (posture, fatigue, central regulation) and itself adapts after OVD changes. Interocclusal distance averages about 3 mm but ranges from about 1 to 9 mm in healthy patients.
Rest position minus freeway space. Establish the habitual rest position, then subtract about 2–4 mm (commonly 3 mm). Most widely used, limited by rest-position instability.
Phonetics. Sibilant (“s”) sounds produce a minimum gap of about 1 mm in the premolar region (closest speaking space); “m” sounds help establish rest position; there should be no tooth contact in speech.
Facial esthetics and proportions. Assess lower facial third harmony, lip competence and tooth display.
Other aids. Swallowing (determines OVD and CR functionally), pre-extraction records (photographs, profile tracings, prior casts, a well-adapted existing denture), and restorative space requirements (material thickness, anterior guidance, tooth display, minimizing preparation and avoiding endodontics). Anthropometric and cephalometric methods (for example finger length correlations) have been proposed; routine use of orthodontic cephalometric norms is discouraged as unreliable.
Evaluate before committing. A 2025 systematic review concluded that increasing OVD should be preceded by an evaluation phase using interim or transitional restorations, or a removable appliance, to confirm functional and esthetic tolerance before irreversible treatment. Transitional bonding (direct composite or CAD/CAM) is a reversible way to trial a new OVD.
Verification criteria. Adequate freeway space at rest, sufficient interocclusal space for the prosthesis, no tooth contact during speech, patient acceptance and comfort, and an esthetically acceptable profile.
Record and transfer. Use an anterior deprogrammer to stabilize the mandible and record the intended OVD at the CR position, then facebow transfer and articulator mounting at the determined OVD with CR records.
Choose the horizontal reference. For complete mouth rehabilitation, a consensus recommends restoring partially and completely dentate patients in CR-coincident centric occlusion, since most patients do not have coincident CO and MIP and the discrepancy is associated with occlusal instability and TMD. CR is the recommended reference when posterior support is lost and no stable MIP exists.
Digital option. Intraoral and facial scans, CBCT and jaw-motion or electronic facebow tracking can be integrated in a virtual patient to determine OVD and CR, deliver a therapeutic position, and double-check it before irreversible preparation.
Cautions and limits
A consensus statement found the stomatognathic system tolerates alteration of OVD well in healthy patients, and that OVD can be restored successfully with proper diagnosis and planning, but biologic variability undercuts any single formula.
No clinical evidence was found that abraded teeth in bruxers continuously erupt to compensate; unopposed teeth do over-erupt. Lost OVD in generalized wear is generally recoverable, and space often exists where occlusal contact has been maintained.
Evidence is mainly consensus statements, reviews, case reports and technical reports; the finger-length correlation and digital workflow data are limited.
Evidence summary
Moderate to limited. Based on an American College of Prosthodontists best-evidence consensus statement, systematic and narrative reviews on OVD in complete dentures and on the evaluation phase, a randomized trial on finger-length correlation, technical reports and case reports on digital workflows.
Transitional bonding to trial a new OVD before definitive restorations
Scope: Using additive, adhesively bonded interim restorations at the planned CR and OVD to test esthetics, phonetics, comfort and occlusion before irreversible treatment.
Use when
A planned increase in OVD (wear, erosion, full-mouth rehabilitation) needs to be tested reversibly with little or no tooth preparation.
Protocol
Diagnostic records. Photographic series, radiographs, full-arch impressions or scans, CR bite registration and facebow transfer; mount on a semi-adjustable articulator.
Set CR and target OVD. Deprogram (Lucia jig or anterior deprogrammer), establish CR, then set the target OVD at that position.
Wax-up or digital mock-up at the planned OVD. It defines the additive contours and serves as the matrix template.
Minimal surface preparation. Remove aprismatic enamel with air abrasion or a coarse diamond to improve bond strength; little to no dentin removal.
Direct option. Duplicate the wax-up as a vacuform or PVS putty matrix, load with composite and apply to etched, bonded teeth. A single-visit staged approach has been described: prepare and provisionalize one arch, then use matrix-guided composite on the unprepared, etched opposing arch to hold the new OVD until full-contour interim prostheses are placed.
Injectable composite option. Flowable composite through a clear matrix can provisionally rehabilitate the full mouth at an altered OVD and CR, and stabilize failing or eroded surfaces. Counsel the patient that it is transitional; in the published report definitive restorations followed within about 3 years, placed segmentally as finances allowed.
CAD/CAM option (indirect additive). More efficient, homogeneous and wear-resistant than chairside layering, which is tedious and prone to isolation and contamination problems. Scan mounted models or intraorally, capture a buccal bite scan in CR at the determined OVD, design the onlay from the wax-up copy, mill and polish composite, try in, then bond. Milled composite blocks meet short-term (3–12 month) requirements and can be milled thin enough for minimally invasive onlays.
Prepless digital design. An ultraconservative “copy-paste” transitional phase uses prepless posterior overlays plus anterior veneers bonded at the new maxillomandibular relationship, so the patient can trial the OVD and smile before definitive ceramics.
Evaluate for about 3 months (range about 3–6) for esthetics, phonetics, comfort and balanced bilateral occlusion. Adjust as needed.
Transition to definitive restorations, often segmentally by quadrant, using the interim restorations as the blueprint.
Cautions and limits
Direct composite restorations placed at an increased OVD (posterior disclusion of 1–4 mm) for localized anterior wear achieved an 89.4% success rate at 30 months in one study; maintenance needs varied substantially with the material and adhesive system.
A prolonged or incremental OVD trial (for example ½ mm per week) is not evidence-based. A 2025 scoping review found staged augmentation protocols rest on expert opinion and have not been scientifically validated, and that the required trial duration has not been defined; most patients adapt well. The trial mainly verifies esthetics, phonetics and acceptance and refines the occlusal scheme.
Evidence is mostly reviews, clinical and technical reports and one 30-month case series.
Evidence summary
Moderate to limited. Based on a narrative review, clinical and technical reports, one 30-month case series and a 2025 scoping review; no controlled trials define the optimal trial duration.
Confirming adaptation to an increased OVD before definitive restorations
Scope: Clinical criteria for judging that a patient has tolerated a new OVD during the interim or trial phase, and when a formal reversible testing phase is indicated.
Use when
Deciding whether an interim or prototype phase at an increased OVD can be converted into definitive restorations.
Protocol
Accept the limit. No validated, quantifiable gold-standard parameter confirms OVD tolerance. Adaptation is judged on clinical and functional criteria. The stomatognathic system tolerates moderate increases well (reported up to about 5 mm at the incisal level).
Occlusion. Even, bilaterally balanced contacts; provisionals adjusted until chewing, speech and breathing function are maintained.
Symptoms. The patient stays free of myofascial pain, muscle fatigue and TMJ signs through the evaluation window. This is the main aim of a pretreatment testing phase in TMD, uncertain-bite or large-OVD-change cases.
Phonetics. No tooth contact in speech; “S” and “F” sounds serve as functional guides. Phonetic adaptation is the least predictable outcome but typically resolves within about 2 weeks.
Freeway space. Interocclusal distance at rest generally 2–4 mm, showing the new OVD has not encroached beyond the physiologic rest position.
Patient comfort and esthetics. Patient acceptance, facial harmony, lip and profile, lower-facial-third proportions. A full-mouth mock-up can be modified intraorally in response to feedback.
Duration. The interim phase is conventionally assessed over about 3 months, with restorations monitored and adjusted, then used as the blueprint for the definitive prostheses.
Choose the testing method by risk. A formal reversible (removable appliance) testing phase is most strongly indicated for patients with TMD, large OVD changes or an uncertain bite, where symptoms should be controlled before any irreversible procedure.
Cautions and limits
A 2025 scoping review found staged augmentation (for example ½ mm per week) rests on expert opinion and has never been validated, and that research defining the required trial duration or objective endpoint is lacking. Most patients adapt well.
Electromyography studies show muscle activity falls within a week of OVD elevation, more after a month, and returns to baseline by about 3 months (the basis of the traditional 3-month recommendation). This reflects transient muscle-recruitment change, not a required reset before definitive work.
Reported complications after OVD increase (muscle fatigue, speech difficulty) are minor, affect a small subgroup and mostly resolve within about 2 weeks.
A systematic review found patients can be successfully restored with or without an evaluation phase; a testing phase was used in 80 of 103 articles and omitted in 23. When omitted, use minimally invasive or no-preparation approaches so the plan stays reversible.
Removable appliances carry their own compliance, esthetic and discomfort disadvantages.
Evidence summary
Moderate to limited. Based on a systematic review of the evaluation phase, a scoping review, a randomized trial of testing an increased vertical dimension with a removable appliance, a narrative review and clinical case reports; no objective adaptation endpoint is validated.
Controlling TMD symptoms before irreversible OVD change
Scope: Sequencing conservative TMD management and splint therapy ahead of any irreversible increase in OVD.
Use when
A patient with active or recent TMD symptoms is being considered for full-mouth rehabilitation or an OVD increase.
Protocol
Control symptoms first. Bring pain and dysfunction under control with reversible, conservative therapy, confirm stability, then proceed. Irreversible prosthodontics on an unstable, symptomatic system risks locking in a jaw position the patient cannot tolerate.
Education and self-management. Reassurance about the benign, non-progressive nature of most TMD, soft diet, avoidance of parafunction (clenching, wide yawning), jaw rest, heat or ice.
Pharmacotherapy as indicated. NSAIDs on a time-contingent basis, muscle relaxants for reflex muscle spasm, and for chronic pain consideration of tricyclics or anticonvulsants.
Physical therapy with therapeutic exercise and manual therapy.
Behavioral therapy (CBT, habit reversal), particularly when pain is chronic (>3 months) or there is comorbid distress.
Stabilization (Michigan-type) splint as a reversible adjunct, best combined with counseling. In a pre-restorative patient it also tests the therapeutic jaw position.
Capture the stable position. Once symptoms are controlled, record and verify the stable splint or deprogrammer position, then convert it stepwise into interim and definitive restorations.
Criteria before irreversible OVD rehabilitation. Pain and dysfunction resolved or acceptably controlled (no masticatory muscle or TMJ pain on palpation, adequate mouth opening, stable symptom course); a reproducible, stable CR or maxillomandibular position at the intended OVD; orthopedic stability maintained through the planned change, keeping the increase minimal and ideally under 5 mm interincisally; demonstrated adaptation using the splint, then interim restorations at the new OVD before definitive work.
Refer if symptoms persist despite adequate conservative care: orofacial pain specialist evaluation before committing to irreversible restoration.
Cautions and limits
A literature review concluded that altering OVD does not itself cause TMD, and transient symptoms after OVD change are usually self-limiting. The aim of the pre-restorative phase is a stable, reproducible, pain-free maxillomandibular relationship, not to “treat” the OVD.
Splint efficacy evidence is moderate to low and the mechanism (occlusal effect versus placebo or regression to the mean) is unresolved. A randomized trial found that adding a stabilization splint to non-splint multimodal therapy gave no additional benefit for pain, mouth opening or joint sounds. The Cochrane review found low-certainty evidence for occlusal interventions, with a hard stabilization splint plus counseling possibly more effective than other single modalities.
Do not read splint-induced OVD increase that relieves symptoms as an indication to raise OVD permanently. After symptoms resolve, withdraw the appliance gradually and attempt permanent occlusal changes only after the patient demonstrates adaptability.
A 2025 consensus and systematic review found no robust evidence that a formal evaluation phase is strictly necessary for success, though it helps manage expectations in complex cases. For active TMD, large planned OVD changes or an uncertain bite, a reversible testing phase to achieve symptomatic stability remains the prudent approach.
Evidence summary
Limited. Based on narrative reviews, Cochrane reviews of psychological therapies and occlusal interventions (low-certainty), a systematic review of splint therapy, randomized trials and a 2025 consensus statement; no trial tests TMD control as a precondition for OVD change.
Toothpaste selection: fluoride is the essential ingredient
Scope: Evidence-based recommendation of toothpaste by active ingredient, concentration and patient age or caries risk.
Use when
Advising patients on a daily toothpaste, or adjusting fluoride concentration to caries risk.
Protocol
Recommend a fluoride toothpaste of at least 1000 ppm for essentially all patients. High-certainty evidence from a 2019 Cochrane network meta-analysis (96 RCTs) shows 1000–1250 ppm and 1450–1500 ppm toothpastes prevent caries more than non-fluoride toothpaste, with a dose-response: 1450–1500 ppm slightly outperforms 1000–1250 ppm (moderate certainty), and concentrations above about 1500 ppm add little in children and adolescents. In adults, 1000–1100 ppm reduces DMFS versus placebo.
Fluoride salt matters little. Sodium fluoride, sodium monofluorophosphate, stannous fluoride and amine fluoride are considered roughly equivalent for caries prevention.
Match concentration to age and caries risk. US over-the-counter toothpastes contain 1000–1100 ppm; prescription formulations up to 5000 ppm are used for high-risk adolescents and adults.
Children under 6. They swallow toothpaste more and are more prone to fluorosis. The American Academy of Pediatrics advises a rice-grain smear under age 3 and a pea-sized amount (about 0.25 mg F) at ages 3–6, supervised brushing, and storing toothpaste out of reach.
Add gingivitis control with stannous fluoride when antiplaque or antigingivitis benefit is also wanted. It combines anticaries and antimicrobial action and significantly reduces gingivitis, though its antiplaque effect is small and inconsistent across studies.
Other agents are adjuncts. Zinc citrate has antiplaque, anticalculus and anti-malodor effects; pyrophosphates and zinc citrate reduce calculus; chlorhexidine is a prescription-strength antiseptic for severe gingivitis, with staining and allergy risks on long-term use.
Hypersensitivity. Potassium nitrate, arginine, strontium salts, stannous fluoride, hydroxyapatite and calcium sodium phosphosilicate reduce dentin sensitivity by occluding tubules or reducing nerve excitability.
Whitening. Mild abrasives, low-concentration peroxide or blue covarine (an optical effect). Charcoal dentifrices are discouraged because of high abrasivity and insufficient evidence.
Cautions and limits
Triclosan/copolymer toothpaste shows moderate-certainty reductions in plaque (about 22%), gingival inflammation (about 22%) and bleeding (about 48%), and a small additional caries reduction, with no serious safety concerns in trials up to 3 years. Because of thyroid-disruption and antibiotic-resistance concerns it has been off the US market since 2019.
Surfactants such as sodium lauryl sulfate are among the most biologically active ingredients and have been linked in vitro to mucosal disruption and increased epithelial permeability, and fluoride salts show dose-dependent cytotoxicity in vitro at high concentrations or prolonged exposure. These are in-vitro signals and do not outweigh the established clinical benefit of fluoride.
Modern toothpastes contain roughly 20 of about 185 possible ingredients; most non-fluoride additives offer smaller, more variable or cosmetic benefits.
Evidence summary
Strong for fluoride (high-certainty Cochrane network meta-analysis); moderate to limited for adjunct agents (stannous fluoride, zinc, desensitizers), based on a Cochrane review, narrative reviews, a pediatric guideline and in-vitro studies.
Desensitizing toothpaste for dentin hypersensitivity
Scope: Choosing and counseling on a home-use desensitizing dentifrice, and when to escalate to in-office treatment.
Use when
A patient reports cold, air or tactile dentin sensitivity and home care is the first step.
Protocol
First-line recommendation. Twice-daily stannous fluoride or arginine (with calcium carbonate) dentifrice. A 2026 network meta-analysis (93 studies, 9,548 participants) found both gave the most clinically meaningful reductions in evaporative cold and tactile sensitivity versus a benchmark fluoride toothpaste. Stannous fluoride had high-certainty evidence for cold-stimulus relief; arginine had comparable effect sizes with lower certainty. Choose by preference, tolerability and availability.
Alternatives. A 2020 network meta-analysis (125 RCTs, 12,541 patients) ranked calcium sodium phosphosilicate (CSP, bioglass) most beneficial across tactile, cold and air stimuli. Potassium salts, potassium plus stannous fluoride, potassium plus hydroxyapatite, strontium and nano-hydroxyapatite also outperformed plain fluoride for one or more stimuli.
Know the mechanisms. Potassium salts (nitrate, chloride, citrate) depolarize the nerve by raising extracellular K+. Stannous and sodium fluoride form insoluble precipitates; arginine plus calcium carbonate deposits plugs in tubules; CSP releases calcium and phosphate that precipitate in tubules; nano-hydroxyapatite crystallites occlude tubules and may aid remineralization; oxalates deposit calcium oxalate crystals.
Bioactive glass versus arginine. Mechanistically, bioactive glass (calcium sodium phosphosilicate) releases calcium, phosphate and silicon, raises local pH and precipitates a hydroxycarbonate-apatite layer that continues to mineralize and resists acid; in vitro, bioactive-glass pastes lowered dentin permeability progressively to roughly 15–20% of baseline by day 21. The arginine–calcium carbonate plug also seals tubules and resists acid and pulpal pressure, but is more susceptible to gradual brushing removal and depends on continued twice-daily use. Clinically the two are often comparable: in trials after non-surgical periodontal therapy both relieved root sensitivity within 2–4 weeks and through 8 weeks, with one trial showing a more consistent VAS reduction with bioactive glass. Do not claim a clinical durability advantage for either; arginine has the stronger first-line endorsement, and bioactive glass the stronger mechanistic case.
Nano-hydroxyapatite as a fluoride-free alternative. Nano-hydroxyapatite (n-HAp) is chemically close to tooth apatite and occludes tubules while laying down a biomimetic mineral layer. Randomized trials (for example a 2% n-HAp gel) show significant reductions in tactile, air-blast and VAS scores, and the 2018 meta-analysis of 53 RCTs counted it among the active ingredients that beat negative control. In the 2020 network meta-analysis it appeared mainly as potassium plus hydroxyapatite (tactile SMD 2.47, air SMD 2.44), comparable to bioactive glass and arginine, which keep the stronger high-certainty clinical footing. Treat the three as broadly interchangeable first-line choices; in-vitro occlusion comparisons are protocol-dependent, and an n-HAp advantage at 2–4 weeks reported in one analysis rests on a smaller, shorter evidence base.
Name the products by active ingredient. Bioactive glass: 5% calcium sodium phosphosilicate (NovaMin, e.g. Sensodyne Repair & Protect), 5% fluorocalcium phosphosilicate (Biomin F) and crystallized glass-ceramic (Biosilicate). Arginine: 8% arginine with calcium carbonate and about 1450–1500 ppm fluoride as MFP (Pro-Argin, e.g. the Colgate Sensitive Pro-Relief line), which can also be applied by fingertip as an in-office pre-prophylaxis step for immediate relief. Standard use is twice-daily brushing for about 2 minutes.
Frame it with the hydrodynamic theory. Open dentin tubules allow fluid shifts that activate intradental nerves, so agents either blunt the neural response (potassium, slow, 2–4 weeks) or seal tubules and cut fluid flow (stannous fluoride, arginine, CSP, CPP-ACP, oxalates, resins). Remove the cause first — erosion, abrasion, acidic diet and aggressive brushing — before or alongside any agent. Stannous fluoride also has anti-erosive benefit.
Set expectations. Use twice daily with meaningful relief typically by 2–4 weeks. In an 8-week RCT (120 patients) stannous fluoride gave the best onset, magnitude and rate of complete relief, outperforming potassium nitrate on thermal scores at week 2 and tactile scores by day 3.
Consider combining mechanisms. Potassium (nerve depolarization, 2–4 weeks to act) plus an occluding agent (faster sealing) is biologically complementary. In the 2020 network meta-analysis, potassium plus stannous fluoride gave the largest tactile benefit of any formulation (SMD 3.05) and a large air-stimulus benefit (SMD 2.28), and potassium plus hydroxyapatite also beat single agents. Potassium oxalate delivers both mechanisms in one molecule, though stannous fluoride still led it on onset, magnitude and completeness of relief.
Counsel on timing and the placebo effect. Benefit accrues over 2–8 weeks of twice-daily use, not immediately. Sensitivity also improves in control groups using plain fluoride paste, attributable to better brushing, natural remineralization and expectation, so a modest improvement does not prove the active agent worked; compare against baseline scores over the full period.
Escalate if home care fails. Move to in-office occluding agents (for example glutaraldehyde/HEMA or resin sealants) or other professional treatment.
Cautions and limits
Not supported: strontium alone and amorphous calcium phosphate were not advised in a 2018 meta-analysis (low or very low certainty).
Layering is not always additive: in a 2026 split-mouth RCT, adding adhesive and flowable-resin sealing layers to a potassium nitrate plus glutaraldehyde/HEMA baseline gave no extra benefit over 180 days, suggesting a ceiling once two effective mechanisms are present. By contrast, one trial of strontium acetate dentifrice plus photobiomodulation showed synergy at one month, so the benefit depends on the specific pairing.
The bioactive-glass durability argument rests largely on in-vitro occlusion and permeability data; head-to-head clinical trials mostly show no significant difference from arginine at 8 weeks, and a scoping review noted arginine may outperform bioactive glass in some formulations.
A 2025 trial ranked CPP-ACP, applied as an inunction plus brushing, above arginine and CSP on quality-of-life and pain scores, but this is a single trial with an added application step and should not override the network meta-analyses.
Certainty varies by agent and time point; most non-stannous-fluoride formulations show small to moderate effects with generally low certainty at 2 weeks.
Sensitivity that is spontaneous, lingering or localized may not be dentin hypersensitivity; examine for pulpitis, cracks or caries before treating it as hypersensitivity.
Evidence summary
Strong, with a minus (A-). Based on 2020, 2023 and 2026 network meta-analyses, a 2018 meta-analysis and several randomized trials; certainty is highest for stannous fluoride and varies for other agents.
Non-carious cervical lesions: etiology, prevention and timing of restoration
Scope: Identifying the drivers of cervical dentin exposure, reducing progression, and deciding when to restore.
Use when
A patient has cervical notches or sensitivity at the gingival margin without caries.
Planning prevention before or instead of restoring a non-carious cervical lesion (NCCL).
Protocol
Expect it to be common. NCCLs affect roughly half of adults and 60–90% of older adults, most often premolars. In one clinical series age and premature occlusal contacts were associated with NCCLs and sensitivity.
Identify the mechanisms. Erosion (dietary or intrinsic acid such as reflux or bulimia) is the main driver that opens dentinal tubules. Abrasion (horizontal brushing, abrasive dentifrice) adds to it, and erosion plus abrasion together exceeds either alone. Abfraction (occlusal flexure) is plausible in finite-element models but has little clinical proof, so treat it as a possible contributor, not a diagnosis.
Look for contributing factors. Gingival recession, reflux, asthma, medications that reduce saliva, parafunction and age. Advanced cervical wear with shallow pockets and little plaque points toward abrasion combined with erosion.
Control acid exposure. Reduce between-meal acidic food and drink, pair acids with cheese or dairy at meals, and do not brush immediately after acid exposure. Refer intrinsic sources (reflux, eating disorders) for medical care.
Modify brushing. Soft brush, light pressure, vertical or small circular strokes, and a low-abrasivity (low-RDA) dentifrice.
Protect and desensitize. Fluoride and a desensitizing dentifrice; see the desensitizing toothpaste protocol.
Manage occlusion when indicated. Consider a night guard or other occlusal management for parafunction or premature contacts; evidence is weaker.
Delay restoration when possible. Restore for caries risk, structural compromise, persistent sensitivity or esthetics. NCCL dentin is sclerotic, so a 30-second phosphoric acid etch, with or without roughening, improves composite bond strength.
Cautions and limits
Counseling alone may not change habits; reinforce at recall and measure progression.
Attributing a lesion to abfraction without excluding erosion and abrasion risks missing a treatable cause.
Several references for this protocol are listed by DOI or PubMed ID only; confirm full citations before external use.
Evidence summary
Moderate. Etiology rests on observational studies and reviews, and prevention evidence is mostly indirect. Occlusal management and abfraction are the weakest links.
Pain during caries excavation in a maxillary molar despite local anesthesia
Scope: Recognizing incomplete pulpal anesthesia in an upper molar, supplementing it, and reassessing the pulpal diagnosis.
Use when
A patient feels pain while excavating caries in a maxillary molar after buccal infiltration.
Soft-tissue numbness is present but dentin is still sensitive.
Protocol
Stop and confirm the deficit. Soft-tissue (lip, cheek, gingival) numbness does not guarantee pulpal numbness. Allow full onset time, which can take several minutes after maxillary infiltration, then retest with cold or gentle dentin probing before resuming.
Think incomplete anesthesia first. Buccal infiltration alone often fails to give profound pulpal anesthesia in molars, and success falls further in inflamed teeth. Deep caries implies an inflamed pulp, so pain on excavation is expected more often than it is anomalous.
Consider the palatal root. A palatal root apex far from the buccal cortical plate predicts failure (one study found a distance above about 12.3–12.5 mm was significant). Add a palatal infiltration near the palatal apex or an intraseptal injection, which improved pulpal anesthesia of maxillary first molars.
Escalate in order. (1) Palatal or intraseptal supplement; (2) a second buccal infiltration with 4% articaine; (3) intraligamentary (PDL) injection as a supplemental technique when infiltration fails.
Reassess the pulpal diagnosis. Cold and percussion testing plus a periapical radiograph if excavation approaches the pulp or symptoms are spontaneous. Brief, non-lingering cold pain with normal percussion favors reversible pulpitis; lingering, spontaneous or throbbing pain and percussion tenderness favor irreversible pulpitis, which is harder to anesthetize and changes the plan (vital pulp therapy versus root canal treatment).
Treat persistent failure as a clue. Difficulty achieving anesthesia despite supplementation suggests irreversible inflammation or necrosis; shift the treatment plan accordingly.
Cautions and limits
Do not miss an acute apical abscess or spreading odontogenic infection: spontaneous throbbing pain, marked percussion or bite tenderness, swelling, a negative vitality response, or fever, trismus, lymphadenopathy or difficulty swallowing need urgent management rather than continued restorative work.
Most trial data are in symptomatic irreversible pulpitis; extrapolating success rates to teeth with reversible pulpitis is uncertain.
Dosing and technique should follow the drug labeling and the clinician’s training; this protocol does not set doses.
Evidence summary
Moderate. Supplemental techniques are supported by randomized trials, mostly in maxillary first molars with symptomatic irreversible pulpitis. Diagnostic distinctions rest on smaller diagnostic-accuracy and biomarker studies.
Tonsilloliths (tonsil stones): recognition, imaging pitfalls and referral
Scope: Recognizing a tonsillolith as an incidental or symptomatic finding, avoiding imaging misdiagnosis, and deciding between home care and ENT referral.
Use when
A panoramic or CBCT image shows a radiopacity near the mandibular ramus.
A patient reports halitosis, a foreign-body sensation in the throat or recurrent sore throat, and oral causes are not explanatory.
Protocol
Know what it is. A tonsillolith is a calcified concretion in a tonsillar crypt formed from desquamated cells, microorganisms and debris. Stones under about 5 mm are common; larger ones are rare. Most are asymptomatic.
Consider the oral link. The microbiota overlaps with dental plaque (for example Actinomyces, Fusobacterium, Porphyromonas, Prevotella, Tannerella), and one CBCT study associated stone characteristics with periodontal bone loss. Assess periodontal status and oral hygiene.
Examine. Inspect and palpate the tonsils; physical examination is usually sufficient. Symptoms when present include halitosis, foreign-body sensation, recurrent sore throat, odynophagia, bad taste, otalgia and hoarseness.
Read imaging with care. On a panoramic film a tonsillolith can overlie the mandibular ramus even though it lies in oropharyngeal soft tissue. If the diagnosis is uncertain or the stone is large, CT helps distinguish it from sialoliths, phleboliths, calcified lymph nodes, an elongated styloid process and minor salivary gland tumors.
Rule out oral-source halitosis first. Check tongue coating, periodontal disease and caries; recommend tooth brushing, tongue scraping and saltwater gargles.
Manage expectantly when stones are small, asymptomatic or self-extruding. Gentle manual expression of accessible stones is described, but patients should not probe with sharp objects.
Refer to ENT for persistent or recurrent symptomatic stones, large or non-extruding stones, or when imaging is inconclusive. In adults, laser cryptolysis may be preferred to tonsillectomy for refractory cases to avoid general anesthesia; tonsillectomy is reserved for persistent, large or recurrent cases.
Cautions and limits
Evidence for procedural treatment of tonsillar halitosis is limited by a lack of high-quality studies; procedures are not appropriate for subjective halitosis, non-tonsillar causes, or when medical management resolves symptoms.
A large stone can mimic abscess or neoplasia; do not assume a calcification near the ramus is benign without considering the differential.
Much of the prevalence and risk-factor evidence is retrospective or case-based.
Evidence summary
Limited to moderate. Recognition and imaging pitfalls are supported by radiographic and review sources; management evidence is weak, with few high-quality studies.
Tonsilloliths and periodontal bone loss: assessing an incidental finding
Scope: What to do when a tonsillolith is found on CBCT or panoramic imaging and how it relates to periodontal status.
Use when
A tonsillolith, particularly a large or multiple ones, is seen on CBCT or panoramic imaging.
Protocol
Know the association. A 2025 CBCT retrospective study (171 patients with tonsilloliths, 171 matched controls, all systemically healthy) found moderate-to-severe bone loss significantly more prevalent with tonsilloliths. Stone size correlated with bone loss severity (ρ = 0.274), larger stones were associated with furcation defects, and these patients had more missing teeth.
Note the discrepancy. An earlier CT study found the number of stones, not their size, correlated with bone loss. A panoramic study detected tonsilloliths in 16.4% of 859 patients, with more missing teeth, apical periodontitis and bone loss in those patients. Apical lesions were not significantly associated in the CBCT study.
Perform a careful periodontal assessment with probing, bleeding, mobility and furcation evaluation, plus radiographic bone levels, for patients with an incidental tonsillolith.
Reinforce plaque control and tongue cleaning, and treat periodontal disease on its usual indications.
Do not promise a tonsil benefit from periodontal therapy. Non-surgical therapy shifts subgingival and salivary microbiota toward health and reduces intra-oral halitosis, but no interventional study shows it lowers tonsillar colonization or tonsillolith recurrence. One trial noted that A. actinomycetemcomitans persists on tonsils, and tonsils may act as an independent reservoir. Stones also change spontaneously (in one follow-up about 12% disappeared and most increased in calcification density).
Consider dental–ENT coordination when stones are large or multiple, symptomatic, or recurrent. See the tonsilloliths recognition protocol for referral criteria.
Cautions and limits
These data are retrospective and cross-sectional and do not establish causation. Smoking, oral hygiene habits and lifestyle were not available for adjustment.
A proposed bidirectional microbial pathway (shared pathogens such as P. gingivalis, Fusobacterium and T. forsythia in tonsillar crypts and subgingival biofilm) is a hypothesis. Organisms such as Actinomyces also colonize tonsils without stones, so microbes are unlikely to be the sole driver of stone formation.
No evidence shows that removing tonsil stones improves periodontal outcomes, or that periodontal treatment reduces stone recurrence or tonsillar pathogens.
Evidence summary
Limited. Retrospective cross-sectional association studies with possible confounding and conflicting findings on size versus number; prospective studies with clinical periodontal measures are needed.
Keratinized or white tissue distal to the maxillary second molar
Scope: Differentiating normal tuberosity mucosa and frictional keratoses from lesions that need biopsy or referral.
Use when
Thickened, keratinized or white tissue is seen on the maxillary tuberosity or retromolar region as an incidental finding.
Protocol
Know the common benign causes. Normal keratinized tuberosity mucosa; benign alveolar ridge keratosis (BARK), a frictional white plaque with fading margins and no erythema or ulceration that is a lichen-simplex-chronicus-type reaction and not leukoplakia; frictional keratosis or morsicatio from a mechanical irritant; pericoronal tissue over an unerupted third molar; traumatic fibroma; papilloma; and candidiasis (wipeable).
Take a targeted history. Tobacco (including smokeless), alcohol, areca or betel use; duration and change in size or color; mechanical irritants (sharp cusp, denture, third molar, cheek-biting); pain, numbness, bleeding or loosening teeth.
Examine the lesion. Color, surface (homogeneous versus speckled, nodular or verrucous), borders (fading versus demarcated), induration, ulceration, and whether it wipes off. Palpate the tuberosity, compare the contralateral side, and examine cervical nodes.
Remove irritants and reassess in about 2 weeks. Frictional keratosis should regress when the cause is eliminated. Classic BARK with fading margins and no dysplastic features can be observed.
Image when indicated. A panoramic image if an unerupted third molar, bony expansion or odontogenic lesion is suspected; CBCT or CT if bone involvement is a concern, following ADA/AAOMR selection recommendations. In the posterior maxilla CBCT can show more than panoramic imaging.
Biopsy or refer any white, red or ulcerated lesion that persists beyond 2–3 weeks after irritants are removed, or that is indurated, non-homogeneous, ulcerated or bleeding. A non-scrapable, well-demarcated, fissured or verrucous plaque not explained by friction is a diagnosis of exclusion and warrants biopsy.
Consider the not-to-miss list. Oral leukoplakia or another potentially malignant disorder; proliferative verrucous leukoplakia (persistent, multifocal, verrucous, often gingival); squamous cell carcinoma of the upper gingiva or hard palate, which can mimic a benign keratosis or periodontal problem and affects older women and non-smokers disproportionately; and minor salivary gland tumor presenting as firm submucosal swelling.
Cautions and limits
Persistence and morphology, not first appearance, decide between reassurance and biopsy.
Upper gingival and hard palate carcinoma may invade bone early and present as non-healing tissue or tooth mobility.
Evidence is a mix of consensus reports, reviews and retrospective series; there is no randomized evidence on observation intervals, and the 2-week recheck is a clinical convention.
Evidence summary
Limited to moderate. Based on consensus statements, narrative reviews and retrospective studies; no trials define observation intervals.
Restoring a worn tooth with thin axial walls (under about 1.5 mm)
Scope: Choosing an additive, adhesive approach for molars with deep occlusal wear and thin buccal and lingual walls, including a mandibular second molar.
Use when
Axial walls are under about 1.5 mm and occlusal wear extends into dentin.
A conventional crown would require further reduction of compromised structure.
Protocol
Check supracrestal structure first. About 1.5 mm is the minimum a rubber dam clamp can grasp, and under 1.5 mm between the most apical residual tooth structure and the bone crest is not restoratively feasible without crown lengthening, orthodontic extrusion or periodontal surgery.
Avoid defaulting to a conventional full crown. Subtractive preparation for full coverage can remove a large share (reported up to about 70%) of remaining tooth structure. Retention and resistance form are inadequate with thin short walls.
Build up the walls adhesively. A peripheral build-up (foundation restoration) reconstructs buccal, lingual and proximal walls with composite to create favorable geometry; consider immediate dentin sealing.
Cover the cusps with a bonded partial-coverage restoration. A bonded ceramic or CAD/CAM composite overlay, onlay or occlusal veneer protects thin cusps. In an in vitro study overlay margin type and axial wall length did not significantly change fracture resistance, because adhesion compensates for reduced wall height. A diagnostic wax-up or mock-up can guide a minimally invasive preparation.
Restore the vertical dimension additively when wear is generalized. Use direct composite (template-guided) or bonded indirect restorations, with space created by controlled increase in OVD instead of tooth reduction. A systematic review of minimally invasive full-mouth rehabilitation supports this approach, and a 5-year adhesive case series reported about 90% survival, with posterior restorations failing more than anterior.
Address deep margins. Deep margin elevation with adhesive composite can relocate a subgingival margin for isolation and impression, if rubber dam isolation is possible and the supracrestal attachment is respected. A randomized trial found stable attachment with DME comparable to surgical crown lengthening in endodontically treated posterior teeth.
If a full crown is unavoidable (for example as a bridge abutment), laboratory data support at least 2 mm of axial wall height; 2, 3 and 4 mm outperformed 0–1 mm for adhesively luted all-ceramic molar crowns.
If anchorage is inadequate, create a ferrule first. Orthodontic extrusion preserves bone and the crown–root ratio better than surgical crown lengthening, at the cost of time. For a terminal mandibular second molar, weigh retention against extraction and implant, since ultrathin ceramics perform poorly in the posterior high-load environment.
Bond to sclerotic dentin carefully where cervical lesions are involved: texture the surface with a fine diamond, extend dentin etch to about 30 seconds and bevel enamel.
Cautions and limits
Much of the evidence is in vitro, case series or consensus; long-term randomized data for thin-walled worn molars are scarce.
Deep margin elevation requires reliable isolation and respect for the supracrestal attachment; do not use it to hide biologic width violations.
Address the cause of wear (bruxism, erosion, reflux) or the restoration will be loaded by the same forces.
Evidence summary
Limited to moderate. Based on bench studies, case series, a systematic review of full-mouth rehabilitation, one randomized trial on deep margin elevation and expert consensus. No grade was supplied.
Choosing a bonded ceramic overlay or direct composite for a thin-walled posterior molar
Scope: Selecting between direct composite (including fiber-reinforced) and a bonded ceramic overlay for a structurally compromised molar with thin walls.
Use when
A posterior molar has thin, undermined walls and needs cuspal coverage.
Both direct and indirect adhesive options are feasible.
Protocol
Decide on factors, not survival. Reviews find broadly similar tooth survival between direct and indirect composite; some trials favor direct composite in molars. The choice depends on remaining structure, vitality, load and parafunction, number of teeth, esthetics, cost, chair time and repairability.
Favor direct composite for thin remaining walls where maximal preservation is needed, a single tooth with low-to-moderate load, younger patients, staged or reversible OVD changes, and cost or chair-time constraints. It needs no retentive preparation and is repairable.
Reinforce thin cusps with a short-fiber composite dentin replacement under a cusp-covering composite. In vitro it raised fracture load and shifted failures from catastrophic tooth fracture to repairable chipping.
Favor a bonded ceramic overlay (lithium disilicate) for high occlusal load or bruxism, erosion-dominant wear, multi-tooth or full-arch rehabilitation with high esthetic and longevity demands, and large defects where laboratory fabrication improves morphology and contacts. It requires adequate room for uniform ceramic thickness.
Know the failure patterns. In a worn-dentition RCT, indirect composite tabletops on molars failed about 3.4 times more often than direct composite. Indirect ceramic showed the lowest annual failure rates in one systematic review (0.09–0.83% minor, 0.13–0.33% major). In a 13-year comparison pressed lithium disilicate had 5.5% failure versus 25.3% for CAD/CAM resin composite, with most failures repairable.
Weigh the trade-offs. Ceramic needs more reduction, is brittle, costs more and can wear opposing teeth; composite is conservative, repairable and kinder to antagonists but degrades and discolors faster.
Always cover the cusps. Cuspal coverage and bonding quality, and remaining tooth structure, matter more than the material. Follow the thin-wall restoration protocol for build-up, margin and crown-lengthening decisions.
Cautions and limits
Much supporting evidence is in vitro or from worn-dentition studies with mixed designs; direct head-to-head trials for thin-walled molars are limited.
Composite occlusal veneers showed more surface degradation than ceramic in an erosion RCT, though survival was statistically comparable at 3 years.
Fiber-reinforced results are mainly laboratory data.
Evidence summary
Limited. Systematic reviews and one RCT show comparable survival but heterogeneous populations, and much of the reinforcement and fatigue data are in vitro.
Scope: Selecting and counseling patients for a custom, digitally fabricated, titratable duobloc MAD such as the Panthera X3. Evidence is for the MAD device class; no brand-specific randomized trials were identified.
Use when
Mild-to-moderate OSA, or severe OSA in a patient who is intolerant of, nonadherent to, or declines CPAP.
Anatomically narrow airway with mild-to-moderate collapsibility and low loop gain are the more favorable phenotype.
Protocol
Confirm diagnosis first. Obtain polysomnography or home sleep testing confirming OSA and severity before fabrication.
Choose a custom titratable device. Guidelines favor customized, titratable MADs over prefabricated boil-and-bite and non-adjustable monobloc devices. Panthera X3 changes protrusion in 0.5 mm steps via clips (up to 5 mm forward, 1 mm back).
Titrate to the effective protrusive position. Benefit is dose-dependent, so advance stepwise (here about 0.5 mm per clip change, approximately every two weeks) guided by symptoms, comfort and objective data.
Set expectations. Class-level data show an AHI reduction of about 13.6 events/hour and an Epworth reduction of about 3.8 points. CPAP lowers AHI about 6.2 events/hour more, but sleepiness and quality of life are comparable, and blood pressure falls comparably.
Frame adherence. MAD use runs about 0.7 h/night longer than CPAP with about 50% lower discontinuation, so real-world outcomes can approach CPAP. In severe OSA CPAP remains more effective at lowering AHI and oxygen desaturation index.
Counsel on side effects. Dental/TMJ discomfort, dry mouth, hypersalivation, gum irritation, and with long-term use bite and craniofacial change that can affect efficacy. Schedule periodic dental monitoring.
Weigh the design trade-off. One meta-analysis found monobloc devices improved minimum oxygen saturation by about 11 points versus about 3 for duobloc, though titratable duobloc devices remain guideline-preferred for adjustability.
Verify the result. Repeat a sleep study after titration to confirm therapeutic efficacy, and follow up long term because efficacy can drift.
Cautions and limits
No brand-specific randomized trials of the Panthera X3 were identified; all efficacy figures are MAD class data.
Do not assume FDA clearance for the X3 specifically; verify with the manufacturer.
Dentists do not diagnose OSA; a physician-ordered sleep study is required.
Evidence summary
Moderate for the MAD device class (Cochrane and other systematic reviews, RCT meta-analyses); no brand-specific trials for the Panthera X3.
Postoperative sensitivity after direct composite placement: workup, management and prevention
Scope: Distinguishing benign hydrodynamic sensitivity from hyperocclusion and irreversible pulpitis after a composite restoration, and choosing management and preventive steps.
Use when
A patient reports cold, sweet or biting sensitivity after a posterior composite.
Planning placement in a deep cavity where postoperative sensitivity risk is higher.
Protocol
Know the baseline. Postoperative sensitivity is usually transient and self-limiting, reported in roughly 5–30% of posterior composites depending on cavity depth and configuration, and most cases resolve over days to a few weeks. Cavity depth is the most important associated factor.
Check occlusion first. Pain on biting or percussion suggests a high restoration; adjust before anything else.
Test pulp status. Compare cold response against a contralateral sound tooth and assess percussion, and compare with pre-operative and recall records. Lingering or spontaneous pain, pain that wakes the patient, or a prolonged cold response suggests irreversible pulpitis and needs endodontic evaluation, not desensitizers.
Watch and reassure for mild transient hydrodynamic sensitivity and review.
Desensitize if persistent. Evidence for a topical desensitizer is mixed: one trial found a glutaraldehyde/HEMA agent (Gluma) outperformed two other desensitizers for cold, hot and sweet stimuli, but a larger randomized trial with a universal adhesive found that prior Gluma application did not reduce spontaneous or stimulus-evoked sensitivity at any time point over 12 months. At home, potassium nitrate or tubule-occluding dentifrices (CPP-ACP, arginine/calcium carbonate, calcium sodium phosphosilicate) can be used; CPP-ACP did best in one head-to-head trial. Benefit builds over weeks.
Rule out a cracked tooth. Sharp pain on biting and especially on release, with cold sensitivity, points to a crack. Deep MOD cavities and loss of marginal ridge integrity raise crack risk. Use a bite test and transillumination; optical coherence tomography and micro-CT detect cracks that transillumination misses.
Use cold testing for the pulp decision. Cold is the most practical sensibility test (pooled sensitivity about 0.87, specificity about 0.84) and should be compared with a contralateral control tooth. A brief response suggests reversible pulpitis; a lingering response suggests irreversible pulpitis.
Keep watching deeper restorations. In a case-control study, pulpal deterioration after restorative treatment appeared at a median of roughly 12–14 months, and deeper, multisurface restorations and pulp exposure raised the risk. Recheck vitality at recall rather than assuming a quiet tooth is a healthy one.
Technique matters more than any add-on. A 2026 systematic review of Class II composites found the best outcomes, including less sensitivity, with incremental layering, multi-step (etch-and-rinse or two-step self-etch) adhesives, which gave higher 5-year survival and less hypersensitivity than one-step all-in-one adhesives, soft-start curing (marginal gap about 112 µm reduced to about 45 µm) and sectional matrices. In deep proximal boxes a resin-coating or flowable snow-plow lining gave good comfort, with substantial improvement by one week and no clinically significant difference between the two. Liners give at most a transient 24-hour benefit (Cochrane), so do not rely on them; a calcium-hydroxide or glass-ionomer base over near-pulpal dentin remains common for protection but has weak evidence for sensitivity. In a split-mouth RCT, 940 nm diode laser irradiation of the prepared dentin before bonding reduced postoperative sensitivity after Class II composites.
Replace if a defect is found. If sensitivity persists and a marginal defect or microleakage is identified, remove and re-bond with meticulous adhesive technique.
Prevent at placement. Use incremental placement and controlled polymerization to limit contraction stress, and careful adhesive technique. A desensitizer under the restoration is optional and of unproven benefit: a calcium-phosphate desensitizer had no significant effect in deep and extremely deep cavities in a split-mouth trial, and chlorhexidine cavity disinfection has only limited supportive data. A Cochrane review found little clinical evidence that cavity liners reduce sensitivity under Class I/II composites.
For indirect restorations, immediate dentin sealing reduces early sensitivity (about one week after cementation) in some analyses, but one meta-analysis found no significant difference versus delayed sealing; the benefit appears limited to the early period and more invasive preparations.
Cautions and limits
Total-etch and universal adhesive systems differ in hypersensitivity in trials; follow the manufacturer's protocol and avoid over-drying dentin.
Evidence for the 5–30% range and for specific desensitizers comes from heterogeneous trials with short follow-up.
Do not desensitize a tooth with signs of irreversible pulpitis.
Evidence summary
Moderate to limited. Several RCTs and systematic reviews, but heterogeneous populations, short follow-up and mixed results for liners and immediate dentin sealing.
Benign postoperative sensitivity vs. reversible and irreversible pulpitis: endodontic referral thresholds
Scope: Deciding when post-restorative symptoms warrant observation, desensitizing measures or endodontic referral.
Use when
A patient has persistent or changing symptoms after a restoration.
A tooth with a deep restoration or deep caries needs a pulpal status decision.
Protocol
Classify by pain character. Benign sensitivity and reversible pulpitis give brief, stimulus-provoked pain that stops when the stimulus is removed. Irreversible pulpitis gives spontaneous and/or lingering pain that outlasts the stimulus, classically 30 seconds or more, often referred, poorly responsive to analgesics, sometimes with percussion tenderness.
Benign sensitivity: sharp, brief response to cold, air or biting that improves over days to weeks. Cavity depth is the dominant risk factor (about 4 times higher risk with very deep caries, about 14 times with pulp exposure). FDI criteria accept normal sensitivity or mild pulpal symptoms at follow-up; monitor.
Reversible pulpitis: mild, non-spontaneous, thermally provoked, short-lasting pain that responds to NSAIDs, with no percussion or palpation pain, normal mobility and a normal radiograph. A zone of intact dentin over the pulp supports reversibility.
Irreversible pulpitis (refer): spontaneous or nocturnal pain, lingering cold response (about 30 seconds or more), pain worse lying down, analgesic-refractory pain, rapid and persistent cold response, possible mild percussion pain or thickened periodontal ligament. Refer for root canal therapy or vital pulp therapy.
Pulp necrosis (refer): no response to cold or electric pulp testing versus the contralateral control, possibly with periapical radiolucency, percussion pain or a sinus tract.
Use cold-test duration as an adjunct. Responses of about 4–5 seconds have been associated with reversible pulpitis; about 6 to 10 seconds or more correlate with irreversible pulpitis and higher dentinal MMP-8. Always compare with a contralateral sound tooth and combine cold with electric pulp testing, percussion/palpation and a periapical radiograph.
Suspect asymptomatic irreversible pulpitis after deep caries or a recent deep restoration even if thermal tests are normal.
Prefer cold over electric testing as the first sensibility test (pooled sensitivity about 0.87, specificity about 0.84), always against a contralateral control tooth. A brief response favors reversible pulpitis; a lingering one favors irreversible disease. Absent response with tenderness to percussion or palpation, or an apical radiolucency, points to necrosis with apical periodontitis and warrants endodontic referral; severe pain with swelling or extrusion is an acute apical abscess and is an emergency.
Keep the time course in mind. After deep or multisurface restorations, pulpal deterioration has been reported at a median of roughly 12–14 months, so symptoms that appear late still count.
Act on trends. Record baseline sensitivity before restoration and at every recall. Persistent or escalating symptoms after a reasonable observation interval should prompt endodontic evaluation, not continued desensitizing.
Cautions and limits
Symptoms correlate poorly with histologic pulp state; clinical classification is imperfect and tends to over-diagnose irreversibility.
No single test is definitive.
Several supporting studies are retrospective, questionnaire-based or small; the cold-duration thresholds are associations, not validated cutoffs.
Evidence summary
Limited. Consensus classification (ICOP, FDI) with small observational and diagnostic studies; poor symptom-histology correlation.
Anterior repositioning splint: bite registration, wear, walk-back and what to expect long term
Scope: Running an anterior repositioning splint (ARS) for disc displacement with reduction from registration through staged retraction, and counseling on how long disc recapture lasts.
Use when
A patient has painful reciprocal clicking or intermittent locking from disc displacement with reduction and disc recapture is the treatment goal.
Deciding between an ARS and a stabilization splint, and how to explain expected outcomes.
Protocol
Record the therapeutic position. Guide the mandible forward from full opening into an incisal edge-to-edge protrusion and confirm the reciprocal click is abolished. Target a Class I or super-Class I molar relationship with about 5 mm of premolar-region opening. Splints made edge-to-edge reached about 93.5% MRI-confirmed recapture versus about 54.8% at the least-protruded position.
Confirm recapture on MRI. Image the joint with the registration in place before fabrication. Do not assume recapture from clinical response alone; recapture at insertion is the strongest single predictor of success.
Fabricate a full-coverage maxillary acrylic splint with occlusal indentations and anterior reverse-guidance inclines that lock the mandible into the protruded position. Require uniform, broad contact of the opposing teeth with a stable cusp–fossa interlock, and check and adjust the occlusal surface at insertion.
Set the wear schedule. Wear 24 hours a day except for hygiene for at least about 3–6 months, with monthly review of compliance and progress. There is no standardized schedule. For acute disc displacement without reduction in adolescents, one protocol used about 2 mm of advancement and 2 mm of vertical increase taken right after manual reduction, with continuous wear for the first 1–2 weeks and then tapering to night-only wear to limit posterior open bite and lateral pterygoid contracture.
Walk the splint back. Once the disc is stable, grind about 1 mm of acrylic every 4–6 weeks from the posterior, clearing contacts over the lower premolars and molars so the posterior teeth can settle toward Class I and the occlusal plane can level.
Decide at about 6 months by MRI adaptation of the bilaminar zone and residual molar open bite. Good adaptation: grind the ARS down gradually in preparation for orthodontics or definitive work. Moderate adaptation with molar open bite under 2 mm: replace with a soft splint for at least 3 months. Moderate adaptation with open bite over 2 mm: step-back retraction, with a new construction bite slightly posterior, MRI-confirmed, worn about 3 months and repeated until the occlusion is stable. Poor adaptation: continue the original ARS for at least another month.
Define completion. Treatment is complete when a stable occlusion is re-established and the mandible does not relapse posteriorly after about 6 weeks without the splint. The original occlusion typically re-establishes over 1–2 weeks after daytime wear stops.
Counsel on outcomes honestly. Short-term disc recapture is high (about 92% of joints normal after step-back treatment; up to about 92% at end of treatment in a large cohort) but falls once the splint is stopped: about 72.5% at 12 months in that cohort, with the excellent-outcome rate falling from about 65% to 43%. In another series only about 41% (13 of 32 joints) kept a normal disc–condyle relationship 6 months after stopping. Older clinical series describe about 70% success at 1 year, 53% at 2 years and 36% at 3 years. Symptoms hold up better than disc position: clicking fell from about 90% of joints to about 12% at 12 months, and pain improves even when the disc re-displaces, probably through retrodiscal adaptation and the increase in vertical dimension.
Place the ARS in context. In a 2026 network meta-analysis the stabilization splint ranked highest for pain and the ARS second, with no significant difference between them, and the ARS ranked low for maximum mouth opening. Choose an ARS when disc recapture is the goal, not because it gives better pain relief.
Cautions and limits
Do not flatten the occlusal surface hastily; abrupt posterior repositioning can create a dual bite and symptom recurrence.
Recurrence is common (reported at about 27–59%), and there is no consensus on wear time, adjustment or post-treatment care. Confirm retrodiscal adaptation on MRI before transitioning off the appliance or starting definitive occlusal or orthodontic work.
Predictors of poorer outcome include older age at presentation (late puberty and beyond), greater disease severity or arthropathy, longer symptom duration and unsuccessful disc capture at the initial registration.
Prolonged full-time wear without tapering risks a lasting change in how the teeth meet.
Much of the outcome data is observational, from single-center cohorts, and some improvement reflects the natural course of disc displacement with reduction.
Evidence summary
Moderate. MRI-based cohorts and a network meta-analysis support the short-term recapture and the comparison with stabilization splints; the long-term and wear-schedule recommendations rest on observational series and expert protocols.
Digital workflow for repositioning and stabilization splints: scan, design, print or mill
Scope: Replacing impressions, casts and articulator mounting with an intraoral scan, virtual design and additive or subtractive manufacture, while keeping the registration and wear protocol of the conventional splint.
Use when
Fabricating a repositioning or stabilization splint digitally.
Choosing between a 3D-printed and a milled splint.
Protocol
Capture digitally. Scan both arches and the occlusal relationship with an intraoral scanner and import the data into CAD software with a virtual articulator. This removes the repeated model and record transfers of the analog workflow, each of which adds error. When condylar position must be assessed directly, a CBCT plus intraoral scan can build a virtual articulator with a digital facebow transfer from anatomic landmarks.
Establish the therapeutic jaw position as in the conventional protocol. For a repositioning splint this is the edge-to-edge protrusion that eliminates the click, MRI-confirmed beforehand. In one digital workflow the patient first wore a printed deprogramming device to reach a stable, muscle-relaxed position, and the relationship was then recorded with a silicone bite registration and imported into the software.
Design a semi-anatomic, full-coverage splint 2–3 mm thick with uniform contact of the opposing posterior teeth in the target position, a cusp–fossa lock to hold the position, undisturbed cusp sliding, and no anterior contact or interference in protrusive and lateral excursions. Set the insertion path, block out undercuts and simulate excursions on the virtual articulator before manufacture; a design with an anterior platform can guide occlusal adjustment at delivery.
Manufacture. Print in a biocompatible splint resin (SLA or DLP) with washing, support removal and light-curing, which is cost-favorable and wasteful of little material; or mill from a PMMA blank, which is slightly more accurate but generates substantial nonrecyclable waste and few splints per disc. Accuracy is clinically acceptable for both and efficacy appears independent of the method.
Deliver and verify. Check internal fit and occlusal accuracy and adjust; digital design reduces chairside adjustment but does not eliminate it. Wear schedule and walk-back are identical to the conventional protocol. A lost or damaged splint can be reprinted from stored data without repeating the clinical workup.
Cautions and limits
The registration and the MRI confirmation, not the manufacturing method, determine whether a repositioning splint works.
Direct comparative evidence for digital repositioning splints is limited to small studies and pilot comparisons; much of the digital data concern stabilization splints. Reviews do not yet find digital methods clearly superior enough to abandon conventional impressions.
Evidence summary
Limited. A randomized trial and small comparative studies in stabilization splints, a small study of digital repositioning splints, and pilot comparisons of fabrication methods.
Desensitizers under a restoration and in-office treatments for persistent dentin hypersensitivity
Scope: Deciding whether to place a desensitizer or liner before bonding, and choosing an in-office modality when sensitivity persists or involves exposed dentin.
Use when
Planning a posterior composite in a deep cavity and considering a desensitizer or liner.
Sensitivity persists after a few weeks or involves exposed cervical dentin or non-carious cervical lesion margins.
Protocol
Fix the cause first. Verify and adjust occlusion, and seal the margins with a sound adhesive protocol. Polymerization-shrinkage microgaps and microleakage drive most postoperative sensitivity, and most cases settle within weeks.
Treat an under-restoration desensitizer as optional. Glutaraldehyde/HEMA (Gluma-type) gave mixed results: better scores in one trial, no effect on spontaneous or stimulus-evoked sensitivity over 12 months in a larger trial with a universal adhesive. A calcium-phosphate desensitizer did not relieve sensitivity in deep cavities. Chlorhexidine disinfection has limited supportive evidence.
Do not rely on a liner. A Cochrane review found no consistent benefit of a liner over no liner for postoperative hypersensitivity beyond 24 hours, and a 3-year trial of ion-releasing liners found no significant difference.
If sensitivity persists, start at home. Tubule-occluding agents such as CPP-ACP, arginine with calcium carbonate or calcium sodium phosphosilicate are the usual choices; potassium nitrate acts on the nerve but tends to be outperformed. Strontium toothpaste did not separate from placebo in one meta-analysis.
Escalate in the office by scenario. For exposed cervical dentin or NCCL margins, a resin-based seal (universal self-etch adhesive or S-PRG varnish) has the fastest onset and the most durable relief in head-to-head data: significant relief by day 7, and S-PRG was the only treatment whose 6-month pain reaction time stayed at baseline. Bioactive glass agents occlude tubules with a mineralized layer and work best from immediately to about 4 weeks, with some evidence of sustained effect. Fluoride varnish is the cheap active comparator but the shortest-lived and needs reapplication.
Consider a laser as an adjunct. Lasers beat topical agents over the long term for air-blast pain (standardized mean difference about −0.61) but not for tactile stimuli, and systematic reviews conclude they are not clearly superior to well-applied occlusive or adhesive agents. They add cost; a laser combined with a chemical agent may enhance effect.
Know the duration and laser data limits. A glutaraldehyde/HEMA desensitizer seals by coagulating tubular proteins, with effect lasting up to roughly 30 days per application; fluoride varnish is effective but short-lived and needs reapplication. In an in-vitro study Er:YAG laser plus glutaraldehyde/HEMA gave the highest tubule occlusion (about 96%), but in-vitro occlusion does not establish clinical superiority.
Reassess if pain lingers or becomes spontaneous for high occlusion, a cracked tooth or evolving pulpitis before repeating desensitizing treatment.
Cautions and limits
Heterogeneity across in-office trials is severe (I-squared often above 90%), and the chief conclusions are directional, not definitive. Modalities beat placebo but generally do not separate from one another.
Choice should follow the clinical scenario, cost and operator familiarity; direct superiority data are weak and inconsistent.
Evidence summary
Limited. Several randomized trials and meta-analyses, but short follow-up, very high heterogeneity and mixed results for the under-restoration agents.
Enamel craze lines: recognition, counseling and when to reclassify as a cracked tooth
Scope: Distinguishing superficial enamel craze lines from cracked teeth and deciding between observation and further work-up.
Use when
A patient asks about fine vertical lines on the incisors or occlusal surfaces.
A visible line is found on exam in an asymptomatic tooth.
Protocol
Recognize the lesion. Craze lines are superficial, incomplete fractures confined to enamel, the first and most benign category of the American Association of Endodontists crack classification. They appear as fine lines on occlusal surfaces, marginal ridges and facial surfaces, and are typically asymptomatic with no dentin or pulp involvement.
Confirm there are no symptoms. Craze lines do not produce thermal or bite pain. Pain on biting or release, or cold sensitivity, argues for a deeper crack.
Observe and reassure. No restorative treatment is indicated. Treat esthetically only when the lines, particularly on incisors, are a cosmetic concern.
Re-examine at recall. It is not always possible to confirm clinically that a visible fracture is limited to enamel, so apparent craze lines warrant periodic observation for progression to a deeper incomplete fracture.
Reclassify if symptoms develop. New bite pain, cold sensitivity or staining along the line suggests propagation into dentin. Use selective-pressure (bite stick) testing and transillumination to separate an active deeper crack from a superficial craze line, and plan cuspal-coverage restoration or further work-up for a true cracked tooth.
Counsel on cause. Mastication, parafunction and thermal cycling microcrack enamel; its rod pattern normally constrains propagation, and with normal salivary flow the lines rarely become carious. Head and neck radiotherapy (reduced salivary flow, altered dentin–enamel junction, low oral pH) and methamphetamine abuse increase incidence. Prevalence rises with age: in a near-infrared imaging study 50.7% of maxillary central incisors had craze lines, more often in adults (20 years and older) and more severe from age 40. Orthodontic debonding did not affect prevalence or severity, regardless of appliance type.
Cautions and limits
Depth cannot always be confirmed clinically; do not label a symptomatic line a craze line.
Cosmetic options for craze lines are not well detailed in the sources reviewed.
Etiology data for radiotherapy and methamphetamine come from reviews rather than controlled studies.
Evidence summary
Moderate to limited. Consistent descriptions across clinical reviews and references, with a single imaging study supplying the prevalence and age data.
Last updated 2026-10-16.
Sources
Cracked Tooth — Boushell LW, Journal of Esthetic and Restorative Dentistry (2009)
Cracked tooth: transillumination and bite-test technique, and their limits
Scope: Using transillumination and cusp-by-cusp bite testing together to localize a crack and confirm it is symptomatic, and knowing when to add adjuncts.
Use when
A patient reports sharp, brief pain on biting or on release, or cold sensitivity, without an obvious cause.
A visible line is found and its significance is unclear.
Protocol
Treat the two tests as complementary. Transillumination is a vision enhancer that shows where a crack is; the bite test is a symptom reproducer that shows whether it is functionally significant.
Transilluminate. Clean the tooth, ideally isolate with a rubber dam to remove saliva and glare, and place a fiber-optic light against the crown or root at several points. A crack extending into dentin disrupts light transmission and the line stands out, because its refractive index differs from the surrounding tooth structure. Use magnification (an operating microscope, optimally about 16 times) to find cracks narrower than about 18 micrometers that the naked eye misses. Yellow light and near-infrared sources (810 nm, 1300 nm) have been proposed to improve visualization. Once the tooth is localized, removing restorations and stain further aids visualization.
Bite test cusp by cusp. Place a bite tool (a plastic wedge such as a Tooth Slooth, a rubber disk or a Burlew wheel) over one cusp, have the patient bite, then release. Pain on release is the classic positive finding and isolates the involved cusp. Loading flexes the crack segments apart and release allows fluid and dentin movement that stimulates the pulp.
Interpret together. A localized line on transillumination plus reproduced pain on a single cusp strongly supports a cracked tooth. A line without symptoms may be a craze line; symptoms without a visible line still justify further work-up.
Add adjuncts when equivocal. Methylene blue staining (needs restoration removal and 2–5 days), CBCT (moderate accuracy, limited for narrow cracks), and emerging quantitative light-induced fluorescence and optical coherence tomography.
Cautions and limits
Neither test reliably measures crack depth. Transillumination depends on subjective judgment and underestimates true depth; the bite test gives no depth information.
The bite test cannot reliably tell whether the pain arises from the maxillary or mandibular tooth, and the applied force risks propagating the crack; some authors advise against point-load testing when risk is high.
No chairside test has been validated in a controlled clinical trial, so diagnosis remains a composite of history, symptoms and these reproducible findings.
In an in vitro enamel-crack study, fiber-optic and near-infrared transillumination outperformed the operating microscope (areas under the curve about 0.70 and 0.67 versus 0.57, rising to 0.78 and 0.74 on vestibular and oral surfaces); in a series of 245 teeth with longitudinal fractures, cracks were detected most often with transillumination. These are modest accuracy figures from small or in vitro samples.
Evidence summary
Limited to moderate. Consistent descriptions in clinical reviews, one clinical series and one in vitro validation; no controlled clinical diagnostic-accuracy trial.
Rapid versus slow orthodontic extrusion: forces, rates, anchorage, retention and safety
Scope: Choosing between rapid (forced) extrusion with fiberotomy and slow extrusion that carries tissue, and setting force, anchorage, retention and resorption monitoring.
Use when
A restorative margin must be moved supragingivally (rapid extrusion), or bone and gingiva must be brought coronally for defect correction or implant site development (slow extrusion).
Protocol
Define the goal first. Rapid (forced) extrusion uses heavy force plus repeated circumferential supracrestal fiberotomy to sever the supracrestal fibers so gingiva and bone are left behind, exposing a decayed or fractured margin, creating a ferrule or managing a crown-root fracture. Slow extrusion uses light force over a longer time so gingiva and bone follow the tooth, for infrabony defects, papilla or soft-tissue augmentation and pre-implant ridge development.
Understand the switch. Without fiberotomy the free gingiva follows about 80–90% and the attached gingiva about 80% of the movement, and the bone crest–CEJ relationship stays constant. Fiberotomy converts a tissue-dragging movement into a tissue-sparing one.
Rapid protocol. One systematic protocol bonded a bracket on the target tooth 3–4 mm apical to passive brackets on mesial and distal anchors, applied force above 300 g for a 4-week active phase with weekly circumferential supracrestal fiberotomy and root planing (about two sessions), then a 4-week passive stabilization phase. Mean result: 2.0 mm of tooth movement with only 0.99 mm of gingival and 0.34 mm of bone migration. Pooled data give a mean rate of about 1.5 mm per week (individual studies 1.3–1.8 mm per week). Rigid-bar protocols with elastics use much higher tensile loads (about 5–15 N) and have reached several millimeters in days.
Slow protocol. Use low constant force at a rate not exceeding about 2 mm per month, often with labial root torque to thicken the buccolingual ridge, and retain for more than about a month before extraction or restoration.
Match anchorage to duration. Rapid protocols tolerate simple anchorage (a few adjacent teeth or a rigid composite occlusal bar) because the tooth extrudes faster than the anchors intrude, with a rectangular wire to control anchor tipping; this is not suitable for prolonged therapy. Slow extrusion needs robust anchorage, such as the whole arch splinted with a rigid stainless-steel wire.
Respect the force window. For bodily movement generally 50–100 cN appears optimal, and forces above about 250 cN move teeth only slightly faster at the cost of adverse effects. Finite element work suggests the effective window for extrusion of a canine (about 230–260 g) is higher than for intrusion because the periodontal ligament tolerates tension better than compression.
Retain. Splint the tooth for about 6 weeks after reaching the target, and longer when tissues were intentionally moved, to counter relapse.
Monitor for resorption. Take periodic radiographs. If apical external root resorption is seen, pause active treatment for 2–3 months to allow cemental repair, and prefer light, intermittent forces.
Cautions and limits
Contraindications to any extrusion: ankylosis, hypercementosis, root fracture, pre-existing root resorption, short root length and, in multirooted teeth, risk of furcation exposure.
Extrusion is periodontally favorable because it moves plaque coronally, but root resorption risk is still governed by heavy continuous force, long duration and large apical displacement; case series report low resorption and ankylosis rates.
The rapid-protocol numbers come from a single protocol paper and case series; force values vary widely between appliances and no head-to-head trial compares rapid and slow extrusion.
Evidence summary
Moderate to limited. A systematic review, narrative reviews, a protocol study with outcome measurements and case series; the force-magnitude data come from a systematic review of bodily movement and finite element modeling rather than extrusion trials.
Crown-to-root ratio: classic thresholds, what the evidence shows, and what to weigh alongside it
Scope: Using crown-to-root ratio as a prognostic guide for abutment and endodontically treated teeth, with its limits and the factors that outweigh it.
Use when
Judging whether a tooth is restorable after crown lengthening or extrusion is considered.
Deciding between pre-restorative extrusion, crown lengthening and extraction with replacement.
Protocol
Know the classic thresholds and their source. Shillingburg: 1:1.5 (ratio 0.67) ideal and 1:1 (1.0) the minimum for an abutment. Dykema: 1:2 (0.5) ideal and 2:3 (0.67) acceptable for fixed partial denture abutments. The usual consensus for abutments in a healthy, occlusally controlled periodontium is 2:3 optimal and 1:1 minimum. Many clinicians treat about 1:1 as the point where a tooth moves from favorable or cautious to unfavorable. These figures are expert opinion, not validated decision rules.
Cite the one clinical anchor correctly. A 10-year survival analysis of endodontically treated posterior teeth after osseous crown lengthening found the lowest survival (40%) in teeth left with an inadequate ratio of 1:1 or worse, and crown-lengthened teeth overall were about 2.3 times more likely to be extracted (hazard ratio 2.29). An earlier removable-partial-denture cohort also found a significant rise in abutment failure once the ratio exceeded 1.0.
Use the threshold to choose the procedure. If lengthening would push the ratio to 1:1 or beyond, reconsider: pre-restorative extrusion, which alters the ratio less than crown lengthening, or weigh extraction and replacement. Treat a ratio of 0.67 or less as favorable, up to about 1.0 as the restorable minimum, and 1.0 or more as a strong negative marker.
Measure with the method's bias in mind. Radiographic (2D) ratios systematically underestimate the true anatomic ratio, and 2D and 3D (CBCT) measurements of the same premolar are inconsistent, so a radiographically acceptable ratio may be worse anatomically.
Weigh the factors that matter more. Contemporary data rank a ferrule approaching 2 mm circumferentially and the amount of remaining coronal tooth structure as more decisive than the ratio. In retreated posterior teeth, residual coronal tooth volume of 41% or more was strongly associated with survival, and absence of a ferrule produced the widest variation in post-crown success.
Match the post to the crown. In a large cohort, a post at least as long as the clinical crown and reaching the middle third of the root gave significantly better survival, and a post shorter than the clinical crown performed worst.
Anchor the final decision on ferrule, remaining tooth structure, endodontic status and periodontal support, with the ratio as one prognostic input.
Cautions and limits
The 10-year survival figure comes from a single retrospective cohort of posterior teeth after osseous crown lengthening; extending it to anterior teeth and to extrusion is inference.
No universal numeric threshold has been validated; reviews describe the field as left with vague categories (favorable or unfavorable), and prognostic classifications that include the ratio remain largely experience-based.
Ratio differences measured in vitro or on 2D radiographs may not reflect clinical outcomes.
Evidence summary
Limited. The numeric thresholds are expert opinion; one retrospective survival analysis and a few cohort and meta-analytic studies support the 1:1 cutoff and the greater weight of ferrule and remaining tooth structure.
Restorability: weighting remaining tooth structure, ferrule and crown-to-root ratio
Scope: A sequential framework for deciding whether a structurally compromised or endodontically treated tooth is restorable, with the order of importance of each determinant.
Use when
Deciding whether to restore, rebuild with extrusion or lengthening, or extract a tooth with little coronal structure.
Reconciling a favorable ferrule with an unfavorable crown-to-root ratio, or the reverse.
Protocol
Rank the determinants. Treat remaining coronal tooth structure and ferrule as the dominant, first-order determinants of restorability, and crown-to-root ratio as a secondary modifier that becomes decisive mainly at its extremes (about 1:1 or worse).
Step 1: quantify what remains. Count intact walls and measure residual coronal height and dentin thickness. Teeth with all four walls intact showed essentially no failures in the reviewed data, and at least about 3 mm of residual coronal height is a favorable marker. Molars depend less on a ferrule than single-rooted teeth because the pulp chamber and multiple roots add retention and stress distribution.
Step 2: test whether a ferrule is achievable. Aim for 1.5–2.0 mm of height, at least 1 mm of thickness and ideally 360°. A partial ferrule with at least two opposing walls still helps. See the ferrule protocol for dimensions and figures. Posts help mainly when fewer than two walls remain or no ferrule is possible; they do not replace a ferrule.
Step 3: if the subgingival margin prevents a ferrule, gate on crown-to-root ratio before choosing a method. If the ratio after the procedure would reach about 1:1 or worse, expect a poor prognosis. Where the ratio allows, prefer orthodontic extrusion to osseous crown lengthening, because it preserves more supporting bone and changes the ratio less. See the extrusion and crown-to-root ratio protocols.
Step 4: if no ferrule can be created by any method, favor extraction and replacement over a ferrule-free restoration.
Step 5: integrate the rest. Endodontic quality, periodontal support, fracture-line position and direction, strategic value of the tooth, and patient compliance and maintenance all modify the decision. A vertical fracture extending below the bone is a reason not to treat the tooth.
Classify the tooth. A classification of structurally compromised teeth by remaining wall configuration and margin position helps standardize the choice of build-up and the need for margin relocation.
Cautions and limits
The tiers are a synthesis of systematic reviews, meta-analyses and mostly in vitro data; no single trial has validated the sequence as a whole.
The 1:1 survival figure comes from one retrospective cohort of posterior teeth after crown lengthening; applying it to anterior teeth is inference.
Wall counts and ferrule dimensions are measured differently across studies, so thresholds are guides, not cutoffs.
Evidence summary
Limited to moderate. The ferrule and remaining-structure findings rest on systematic reviews and meta-analyses; the crown-to-root ratio and sequencing recommendations rest on a few retrospective cohorts, in vitro studies and expert synthesis.
Immediate dentin sealing: adhesive selection, flowable coating and technique
Scope: Technique for sealing freshly cut dentin before impression for indirect restorations, including which adhesive to use and when a flowable coat is needed.
Use when
Preparing a vital tooth for an adhesively luted indirect restoration (inlay, onlay, veneer, bonded crown).
Protocol
Timing and isolation. Apply the seal immediately after preparation, before impression or provisionalization, on fresh uncontaminated dentin under rubber dam. Apply it before the impression, not after, to avoid resin pooling at the margin.
Choose a filled multi-step adhesive. A filled three-step etch-and-rinse adhesive (OptiBond FL, Scotchbond Multi-Purpose) or a two-step self-etch (Clearfil SE Bond, 10-MDP) is preferred; simplified single-bottle adhesives seal dentin less reliably. Filled adhesives give a uniform, radiopaque film and avoid the pooling and incomplete polymerization of air-thinned unfilled resin.
Add a flowable coat when the adhesive is unfilled or lightly filled. A 0.3–0.5 mm light-cured flowable layer protects the interface from oxygen inhibition, resists damage during pre-delivery cleaning and seals tubules the adhesive alone leaves patent; in vitro, it raised Clearfil SE Bond microtensile strength to about 45.6 MPa, comparable to OptiBond FL. With OptiBond FL the coat is optional and mainly maintains bond strength.
Self-etch sequence (published technique). Scrub primer 20 s, air-dry 10 s; apply bonding resin 20 s, air-dry and light-cure 20 s; add the flowable coat and cure 20 s; apply glycerin gel to block oxygen inhibition and cure a further 20 s, then rinse it off. Then take the impression and provisionalize.
OptiBond FL specifics. For IDS the filled adhesive resin is applied actively for the manufacturer time and not air-thinned, leaving a thicker protective coat; this is why it reached the highest IDS bond strength in vitro (about 54.8 MPa alone, 52.5 MPa with a flowable, so the flowable neither helped nor hurt). Reported sequence: 37% phosphoric acid 15 s, rinse, leave dentin moist; primer scrubbed 15 s (some protocols apply it twice on fresh cut dentin) and gently dried; adhesive scrubbed 15 s, light-cured; then glycerin gel and a further cure, rinsing the gel away. Follow the current instructions for use for exact times.
One-step universal adhesives (for example Clearfil Universal Bond Quick). The latest formulation with urethane tetramethacrylate and nano-fillers reached dentin bond strength comparable to Clearfil SE Bond 2 in vitro, but the earlier version matched it only with a 20 s dwell before curing, not the passive quick technique. Apply actively with adequate dwell and solvent evaporation, consider a second layer on moist bur-cut dentin, and always add a flowable coat: simplified adhesives gained roughly 200–500% in bond strength with a flowable but showed little benefit from IDS alone. Keep selective enamel etching, because self-etch mode bonds enamel margins less reliably. These are in vitro data, not IDS trials.
Keep “gold standard” in context. OptiBond FL and Clearfil SE Bond (reinforced) lead for in vitro IDS bond strength, but a systematic review found neither retained non-carious cervical lesion restorations better than other adhesives at follow-ups out to 9–13 years. Choose between them on technique sensitivity and workflow; a 2026 study found the highest ceramic-to-dentin shear bond strength with OptiBond FL, a resin provisional and waterborne alumina cleansing.
Do not air-thin an unfilled adhesive as a substitute for a filled layer; thin unfilled resin polymerizes poorly and some resin-liner and impression-material combinations are incompatible.
Match monomers at cementation. Bond strength to the sealed layer is optimized when the sealing adhesive and resin cement share compatible functional-monomer chemistry (for example GPDM with GPDM, or 10-MDP systems).
Re-treat before delivery. Remove provisional cement residue and condition the sealed surface (pumice and air-particle abrasion with about 29–50 µm alumina) before final cementation; a well-cured seal retains bonding capacity through residual methacrylate groups and micromechanical retention.
Cautions and limits
Most bond-strength findings come from in vitro studies and small trials; the clinical advantage for sensitivity is confined to roughly the first week, so choose IDS for bonding benefit, not sensitivity alone (see the post-preparation sensitivity protocol).
Specific products and times are those in the cited technique papers; follow the manufacturer's instructions for the adhesive actually used.
Evidence summary
Limited to moderate. A systematic review supports sensitivity and survival benefit, while the adhesive-selection, flowable-coating and monomer-matching recommendations rest mainly on in vitro bond-strength studies and a few technique papers.
Reducing polymerization shrinkage stress in direct composites: curing mode, layering, liners and materials
Scope: Choosing curing protocol, placement technique, intermediate layer and material to lower shrinkage stress, a driver of gaps, microleakage and postoperative sensitivity.
Use when
Placing a posterior composite in a deep or high C-factor cavity.
Choosing between bulk-fill and incremental placement, or adjusting the curing protocol.
Protocol
Modulate the light cure. A systematic review and meta-analysis of 36 in vitro studies found alternative light-curing sources and modulated photo-activation (intermittent, exponential, soft-start, pulse-delay) reduced stress more than placement technique or simply changing irradiance or total energy. Exponential and pulse-delay modes reduced stress for all resins in one study; pulse-delay is impractically long, so an exponential or soft-start protocol is the clinical choice. Pulse-delay reductions of about 19–32% were attributed largely to lower post-cure thermal contraction.
Protect conversion. Stress reduction from soft-start or pulse curing may come partly from a modest drop in final conversion, and slower polymerization lowers cross-link density. Keep adequate total radiant exposure and avoid over-aggressive ramping.
Layer by default. Oblique or horizontal increments of 2 mm or less increase free surface and lower the C-factor, improving floor adaptation versus bulk placement of conventional composite. Layering also reduced cuspal deflection for several bulk-fill resins, but not all, so layer unless the specific product is validated for bulk placement. Layering is technique-sensitive and time-consuming and risks voids or contamination between layers.
Use a low-modulus intermediate layer in high C-factor boxes. A flowable composite on the walls absorbs stress; the snow-plow (uncured flowable under packable composite) and resin-coating techniques are the clinical forms.
Choose the material deliberately. Bulk-fill resins use stress-relieving monomers, modulators and modified initiators, but marginal-integrity results versus conventional composite are mixed. Thiourethane oligomer or thiourethane-treated filler additives delayed gelation and cut stress by up to about 35% while maintaining conversion, but are a formulation advance, not yet routine. Pre-heating did not reduce stress in direct restorations despite better flow.
Know that dual-cure materials differ by mode. In dual-cure bulk-fill resins, self-cure produced lower stress than light-cure, but follow the manufacturer's instructions for the product used.
Cautions and limits
Most data are in vitro stress-measurement studies; clinical benefit for sensitivity and marginal quality is less certain.
A 24-month RCT compared bulk-fill with incremental placement in vital posterior teeth; follow the validated protocol for the product used.
Do not trade away conversion for stress reduction; under-cured composite fails earlier.
Evidence summary
Moderate for the light-curing and layering effects on stress, which come from a meta-analysis of in vitro studies; limited for clinical outcomes, which rest on a few trials and mixed marginal-integrity data.
Repairing a fractured incisal angle on an existing anterior composite: roughening, universal adhesive and layering
Scope: Chairside repair (rather than replacement) of a fractured mesial incisal angle on a previously restored anterior tooth, using bur roughening, a universal adhesive and a layered nano-composite.
Use when
A localized fracture or deficiency of an aged anterior composite where the rest of the restoration and tooth are sound.
Deciding between repair, fragment reattachment and full replacement for an incisal angle fracture.
Protocol
Decide repair versus replacement. A localized fracture or anatomic deficiency favors repair; severe discoloration, secondary caries or large volume loss favors replacement. In a long-term practice-based study, repairing anterior composites was a viable alternative to replacement. If the intact fragment is available and the tooth is a fresh trauma, compare fragment reattachment with direct composite; one retrospective cohort compared the two.
Select shade before isolation. Choose on the hydrated tooth. Use a dentin or body shade plus an enamel shade (and an optional incisal or translucent shade), judging body color at the mid-facial. Shade-guide tabs and layered composite can differ, so check a cured test increment against the tooth.
Isolate. Rubber dam is preferred for moisture control and predictable bonding.
Prepare the surface. Remove failing or stained composite and any secondary caries, and round sharp internal line angles. Place a long facial enamel bevel (roughly 0.5–2 mm) to expose enamel prisms, enlarge bonding area and blend the shade.
Roughen the aged composite. A coarse or medium diamond bur raised repair bond strength in the studies reviewed, and with a self-etch-type universal adhesive gave the lowest microleakage in one micro-CT study; a network meta-analysis of aged-composite repair supports mechanical roughening as a core step. Air abrasion is an effective alternative.
Condition. Etch enamel with 37% phosphoric acid for about 30 seconds and freshly exposed dentin for about 15 seconds, rinse well and air-dry gently, leaving dentin slightly moist. On the old composite, acid mainly cleans the ground surface and adds little after bur roughening, but it is reasonable if saliva or blood contaminated it. Because the margin is enamel-rich, etch-and-rinse is preferred here, though a self-etch mode is also supported for composite-to-composite repair.
Silane is optional. Clearfil Universal Bond Quick 2 already contains silane and 10-MDP. Studies on universal adhesives for repair found a separate silane gave no clear added durable benefit after roughening, but results vary by product, so treat this as supported rather than settled.
Apply the universal adhesive. Rub it in, air-dry mildly (at least 5 seconds) until the film no longer moves, then light-cure about 10 seconds. Confirm times against the current manufacturer instructions for the bottle in use.
Build in layers. Place increments of 2 mm or less, curing each per the composite and light manufacturer. A thin flowable first increment against the old composite-tooth interface (the snow-plow approach) can improve adaptation. A lingual silicone index guides the palatal shell, then dentin body with mamelon definition, then enamel or translucent incisal layers to reproduce natural optics and mask the repair line.
Cure the final layer under an air barrier. Glycerin gel or equivalent limits the oxygen-inhibited layer on the surface; keep that layer on any increment that will receive more composite (see the protocol on the oxygen-inhibited layer).
Finish and polish. Use fine and extra-fine diamonds or carbides, then aluminum-oxide discs and strips, then a polishing system suited to high-luster anterior composite (the manufacturer's cups, discs and aluminum-oxide paste). Check occlusion in protrusion and lateral excursions and adjust.
Cautions and limits
Universal Bond Quick 2 is a recent product; its repair performance is inferred from its silane and 10-MDP chemistry and from the wider universal-adhesive repair literature, not from product-specific repair trials.
Most repair bond-strength data are in vitro (shear or tensile bond strength, microleakage, thermocycling), mainly on bulk-fill and nanohybrid composites; clinical longevity of repairs rests on a smaller body of practice-based data.
The incremental-layering and shading sequence is drawn from anterior layering literature and a diastema-closure clinical study, not from controlled trials of incisal-angle repair; follow the composite maker’s shade system.
Etch-and-rinse versus self-etch on the aged composite is not settled; sources in this area differ.
If the fracture is a fresh traumatic injury, assess pulp status and the periodontal ligament before restoring.
Evidence summary
Moderate for bur roughening and universal adhesive as the key repair steps, which come from in vitro studies and a network meta-analysis; limited for the product-specific protocol and for shading and layering sequence.
Oxygen-inhibited layer in composite: when to keep it, when to block it with glycerin gel
Scope: Managing the oxygen-inhibited layer (OIL) of light-cured composite and adhesive: keeping it between increments and excluding oxygen on the final surface.
Use when
Placing the final increment of a direct composite, especially on occlusal or facial surfaces where a matrix strip will not adapt.
Deciding whether to wipe or leave the surface layer between increments or before adding composite to an adhesive.
Protocol
Know what the OIL is. It is a thin, tacky, under-cured film rich in unreacted monomer that forms wherever composite or adhesive is light-cured in contact with air. Oxygen scavenges free radicals, and surface conversion can fall from the usual 55–80% to about 35%.
Keep it between increments. A systematic review of adhesives found the OIL increased bond strength to light-cured composite (and decreased it with chemically cured composite). An in vitro incremental study likewise found the OIL on a fresh increment enhanced interlayer shear bond strength. Do not wipe it off or block it on a layer you will add more composite to.
Block oxygen on the final surface. Place a thin layer of glycerin (air-barrier) gel over the fully contoured last increment and light-cure through it. It works like a polyester strip, excluding air so radicals are not scavenged.
Expect measurable gains at the surface. In vitro, curing under an air barrier raised surface microhardness and degree of conversion (FT-IR values near 90% under glycerin in one study), lowered monomer elution in some composites, and improved color stability, since the weak unpolymerized layer stains more readily.
Remove the gel. Wipe or rinse it away (ethanol or water spray) after curing.
Reserve it for where it helps most. It is most useful where a strip cannot adapt (occlusal, facial and incisal esthetic zones) and where thorough finishing and polishing will be hard to achieve.
Still finish and polish. Oxygen is already dissolved within the resin, so mechanical finishing and polishing remain the most reliable way to remove the weak surface layer and maximize hardness, smoothness and stain resistance. Treat glycerin as an adjunct, not a substitute.
Cautions and limits
Almost all evidence is in vitro (microhardness, conversion, monomer release, staining); clinical benefit of glycerin curing is not established.
Results vary by composite and by curing light, distance and time; conversion figures from one material do not transfer to another.
The adhesive-OIL review and the incremental bond study address bond strength to light-cured composite only; do not extend them to chemically cured materials.
Follow the composite and adhesive manufacturers’ instructions where they specify an air-barrier step or a surface treatment.
Evidence summary
Limited: consistent in vitro findings on surface conversion, hardness and staining, plus a systematic review and an in vitro study on interlayer bonding, but no clinical trials of glycerin curing.
Recognizing TMD symptoms and screening for look-alike diagnoses
Scope: Identifying the cardinal features of TMD in a patient with facial, jaw, ear or head pain, deciding which findings do and do not meet diagnostic criteria, and screening for non-TMD causes before treatment.
Use when
A patient presents with jaw, temple, ear or facial pain, joint noise, limited opening or locking.
A patient reports painless joint clicking and asks whether it needs treatment.
Facial pain does not behave like a typical musculoskeletal pain and an alternative diagnosis must be excluded.
Protocol
Take a pain history. TMD pain is typically unilateral, a dull constant ache, worse at certain times of day (often mornings in those who clench or grind), with sharp exacerbations on chewing, talking or yawning. Ask about radiation to the ear, temple, periorbital region, angle of the mandible and posterior neck.
Classify joint sounds. Clicking or popping suggests disc-condyle incoordination (disc displacement with reduction); crepitus is characteristic of degenerative joint disease. Painless clicking is common in the general population and usually needs no treatment, and isolated painless joint noise does not by itself meet DC/TMD diagnostic criteria.
Measure jaw movement. Record maximum opening (restricted opening is often under 30–35 mm), deviation toward the affected side on opening, and any episodes of locking closed (cannot open) or open (cannot close).
Ask about associated symptoms. Headache, earache, tinnitus, dizziness, reduced hearing, hyperacusis and neck pain are common. In one rapid evidence review the reported frequencies were headache 79%, bruxism 58%, TMJ pain 54%, otalgia 52%, jaw popping or clicking 51%, neck pain 51%, tinnitus 37%, dizziness 37%, decreased hearing 36% and hyperacusis 23%.
Palpate and provoke. Examine the masticatory muscles (pterygoids, temporalis, masseter, sternocleidomastoid) and the joint. A temporal-region headache that is reproduced by jaw function or provocation testing supports headache attributed to TMD.
Subtype. Classify as myogenous, arthrogenous or mixed using the DC/TMD framework. Diagnosis is primarily clinical (history plus examination); reserve MRI for persistent disc displacement and CT for progressive degenerative change.
Screen for alternatives. Consider odontogenic pain, jaw or intracranial tumors, trigeminal neuropathic pain, giant cell (temporal) arteritis, salivary gland disease, and cardiac or systemic causes, particularly when pain does not change with jaw movement or the cranial nerve examination is abnormal. Refer when a non-TMD cause is suspected.
Counsel on course. Most TMD is acute and self-limiting, but roughly 15% progresses to chronic disease; arrange follow-up for persistent or recurrent symptoms.
Cautions and limits
Do not treat painless joint noise alone as a disorder; reassure and observe.
Pain that does not change with jaw function, or any cranial nerve abnormality, should prompt a search for another diagnosis before any TMD treatment.
Symptom patterns differ with age; adolescent and older-adult presentations have been described separately.
Evidence summary
Moderate for the clinical description and diagnostic framework, drawn from review articles (NEJM, American Family Physician, a clinical pain management text and a neurology update on TMD and headache). Symptom frequencies come from a single rapid evidence review and should be read as approximate. Epidemiologic and age-group data (adolescents, older adults, ultrasonography in TMJ arthralgia with headache) are observational.
Stabilization (Michigan-type) splint: design specification, delivery and evidence
Scope: Design parameters, registration, delivery and expectations for a full-arch hard acrylic stabilization splint in TMD, with a summary of efficacy evidence. Repositioning splints and digital manufacture are covered in separate protocols.
Use when
A patient with myogenous or mixed TMD pain, or sleep bruxism with orofacial pain, needs a reversible occlusal appliance.
Counseling a patient on what a stabilization splint can and cannot achieve.
Protocol
Confirm the indication. Diagnose by DC/TMD first. The strongest evidence is for pain of muscular origin; a splint is an adjunct to education and self-management, not a stand-alone cure.
Record the jaw relationship. Take accurate impressions or scans, a facebow transfer and a centric relation registration after deprogramming, and mount on a semi-adjustable articulator (or use a validated virtual articulator).
Why centric relation (CR). CR is a reproducible, musculoskeletally stable condylar position independent of a possibly pathologic intercuspal position, so even contacts built to it do not perpetuate native interferences; deprogramming (bilateral manipulation, chin-point guidance) is thought to reduce muscle hyperactivity. In acute closed lock or painful arthrogenous disease a true CR record may be inappropriate: build at a comfortable, muscularly determined position and refine toward CR contacts at follow-up once pain and guarding resolve.
Choose the design. Full-arch hard acrylic coverage (partial coverage carries more risk of permanent occlusal change and tooth movement); hard and soft splints did not differ at 3 and 12 months, but hard acrylic lasts longer and soft splints may provoke clenching; the maxillary arch is usually preferred, with the mandibular arch used when posterior teeth are missing. Chin-point-guided CR is the most documented registration position, and heat-cured, autopolymerized, thermoformed, milled and 3D-printed splints have not been shown to differ clearly.
Design a full-arch, hard acrylic appliance about 3 mm thick, usually on the maxillary arch, with bilateral, simultaneous, even contacts of the opposing posterior teeth in centric relation and immediate canine-guided disocclusion in excursions, with no posterior contact in lateral or protrusive movements.
Deliver and adjust. Check retention, fit and contacts with articulating paper at delivery, refine the occlusion chairside, and verify that the patient is comfortable with no new muscle or joint pain.
Give wear instructions. Night-only wear is typical because sleep parafunction is the main target (a common trial regimen was nightly wear for 10 weeks, then as needed). Additional daytime wear may be advised for severe symptoms: continuous daytime use was associated with greater efficacy in meta-regression but risks permanent occlusal change, so monitor the occlusion.
Review at 1–2 weeks and again at 4–6 weeks. Re-adjust contacts as muscle tone changes. If there is no meaningful improvement by about 6–8 weeks, reconsider the diagnosis or add physical therapy, behavioral therapy or pharmacotherapy.
Plan the exit. Treat the splint as short-term, reversible therapy. Taper as symptoms settle, and keep a night guard if bruxism continues.
Cautions and limits
Certainty of evidence is low to very low in the Cochrane review of occlusal interventions; benefit versus placebo or non-occluding splints is modest in several analyses.
Cochrane 2024 found very uncertain evidence for a full hard stabilization splint versus a non-occlusal placebo splint, so part of the benefit may be non-specific; counseling, self-care and exercise should accompany every splint. In a network meta-analysis, counseling plus a hard stabilization splint gave the greatest overall improvement, and relying too heavily on the appliance worsens outcomes.
CR as the reference position rests on prosthodontic convention and biomechanical reasoning, not on outcome data: benefit is modest, short-term and similar to other appliances and non-occluding splints. Periodic equilibration is part of the design as muscles relax and the mandible settles.
A splint does not justify irreversible occlusal changes. Full-coverage designs may change joint space and muscle activity compared with partial-coverage designs, and long-term, unmonitored use is not recommended.
Evidence summary
Moderate to low. A network meta-analysis of randomized trials, a meta-analysis of short- and long-term stabilization splint effects, a randomized trial of oral behavior effects, narrative and umbrella reviews, and a 2024 Cochrane review rating the certainty of evidence low to very low.
Acute closed lock (disc displacement without reduction): unlock first, then choose the splint
Scope: Sequencing of manual reduction, arthrocentesis and splint therapy in acute disc displacement without reduction with limited opening, and the choice of bite record when the disc is or is not recaptured.
Use when
A patient presents with acute limited opening from MRI- or clinically-suspected disc displacement without reduction.
Deciding between an anterior repositioning splint and a stabilization splint in a locked joint.
Protocol
Act early. Duration of the lock strongly predicts whether the disc can be recaptured. Confirm the diagnosis (DC/TMD, MRI where available) and rule out other causes of restricted opening.
Attempt manual reduction first. With the patient supine, apply distraction plus forward-downward traction along the condylar axis. In adolescents, manual reduction followed by an anterior repositioning splint (ARS) outperformed physical therapy alone for opening and was associated with less later degenerative change.
Manual reduction technique. Position the patient supine with the head stabilized; one hand on the temporal region of the affected side steadies the head. Place the index and middle fingers over the condyle to feel movement and the reduction click. With the other hand, press the thumb pulp on the affected-side mandibular molars and wrap the remaining fingers around the lower border of the mandible. Apply downward-forward traction along the long axis of the condyle, then guide the patient to maximal opening.
Confirm reduction. A palpable or audible click, an immediate jump in opening to more than 40 mm, and symmetric forward-downward condylar translation compared with the unaffected side. Place the ARS immediately (typically about 2 mm forward and about 2 mm of vertical opening) with continuous initial wear, then taper to night use.
Estimate the likelihood of success. In a retrospective MRI study, a closed-lock duration of 2.75 months or less was the strongest single predictor; a disc displacement angle beta of 96.7° or more and a disc length of 8.39 mm or more were moderate predictors. Longer lock and degenerative condylar change predict failure, probably through disc deformation, loss of bilaminar-zone elasticity and adhesions.
If manipulation fails, add arthrocentesis, then repeat manipulation. In a small MRI-confirmed series of acute cases, this sequence followed by an ARS was clinically successful in about 95%, with a normal disc–condyle relationship on MRI with the splint in place.
If the disc is recaptured, place the ARS immediately. Record the bite right after reduction at the least protrusive, slightly opened position that keeps the disc reduced (no reciprocal click on closing); a hard acrylic or thermoformed full-coverage design with an anterior ramp or block holds the mandible forward. Then follow the ARS step-back protocol.
If the disc cannot be recaptured, or the lock is chronic, use a hard full-arch stabilization splint at a comfortable, adapted position. Do not force bimanual or chin-point CR in a guarded, painful joint; patient-guided records (leaf gauge, anterior jig, swallowing, free closure) carry less risk. CR is one point within a range of normal variation, so a textbook CR should not be insisted on in a diseased joint.
Post-reduction phase 1: full-time ARS wear. Wear the splint continuously except for brushing to hold the recaptured disc–condyle relationship during bilaminar-zone adaptation. Regimens vary: about 3 months full-time then night-only in the MRI-confirmed Lei/Liu protocol; 2 weeks continuous then nocturnal in some protocols; 24 h/day for only the first week in Twin-Block protocols to limit posterior open bite and lateral pterygoid contracture. Watch for posterior open bite, occlusal change and myostatic contracture, and move to night-only use promptly.
Phase 2: exercises. In the adolescent protocol, a tube-biting protrusion/retraction exercise for about 1 month followed reduction and ARS placement. General jaw-mobility, coordination (spatula) and isometric lateral pterygoid exercises can be layered in.
Phase 3: wean and re-establish occlusion. Options: (a) grind about 1 mm from the posterior splint every 4–6 weeks to allow posterior settling, keep the ARS another 1–3 months, and call it complete when occlusion is stable and the mandible does not relapse after about 6 weeks without the splint; (b) step-back ARS retraction for adults with persistent molar open bite above 2 mm after 6 months; (c) graded increase in splint-free time with full discontinuation only after stability is confirmed over consecutive visits. After 6 months of ARS with MRI: good bilaminar adaptation, grind the ARS gradually and prepare for orthodontics; moderate adaptation with open bite under 2 mm, replace with a soft splint for at least 3 months; moderate adaptation with open bite over 2 mm, step-back retraction until stable; poor adaptation, continue the original ARS at least 1 more month.
Refine at follow-up. Build bilateral even contacts with canine guidance, and re-equilibrate as opening improves and the mandibular position settles, moving toward CR contacts once pain and guarding resolve.
Consider arthrocentesis plus a stabilization splint for a short-duration acute lock in a patient with bruxism; a small study reported 90% success at 12 months versus 30% with arthrocentesis alone.
Cautions and limits
Evidence for acute disc displacement without reduction comes from small case series and small trials; the success rates quoted should be read cautiously.
Arthrocentesis relieves pain and dysfunction faster than splint therapy alone, but for chronic closed lock splints, physical therapy, arthrocentesis and arthroscopy have not shown clear differences in opening, pain or function, and most patients improve with conservative care.
Correcting disc position is not required to relieve pain and restore function. Guideline-level sources support manipulation plus exercises and a flat-plane stabilization appliance for patients with restricted movement and minimal pain, and repositioning appliances are not specifically indicated to treat disc displacement without reduction. Randomized trials show similar long-term outcomes for conservative care and arthrocentesis, and many patients improve spontaneously, so manipulation is a low-risk early step, not a definitive cure. The reported 94.6% success with arthrocentesis, hyaluronic acid, manipulation and Twin-Block is also from small acute series.
No standardized weaning schedule exists; wear times, grinding intervals and total duration differ substantially, and most evidence is from small case series and single-center trials. If the disc re-displaces during ARS therapy, refer for TMJ surgical evaluation (arthrocentesis or arthroscopy).
Refer for imaging or surgical opinion if opening does not improve despite adequate conservative and minimally invasive care.
Evidence summary
Limited. MRI-evaluated case series, a controlled adolescent study, small randomized and clinical trials, and narrative reviews.
Posterior open bite with anterior repositioning splints: prevention and management
Scope: Mechanism, risk factors, prevention and correction of posterior open bite, the most frequent iatrogenic complication of anterior repositioning splint (ARS) therapy.
Use when
A patient is wearing, or about to start, an ARS.
A patient reports that the back teeth do not meet after splint wear.
Protocol
Understand the mechanism. Sustained anterior mandibular posturing prevents posterior eruption and intercuspation and can shorten the lateral pterygoid (myostatic contracture), so the mandible cannot fully return to maximum intercuspation when the splint is removed.
Identify higher-risk patients. Greater advancement and vertical opening, prolonged 24-hour wear including eating and speaking, a Class II deep-bite pattern requiring a large advancement, and adult age (less eruptive potential than adolescents, so open bite is more likely to persist).
Minimize the dose. Advance only to the position that eliminates the click and keep the splint height under about 2 mm.
Shorten the continuous phase. After the initial disc-protection phase (commonly about 3 months), move to night-only wear; the original occlusion often re-establishes over 1–2 weeks once daytime wear stops.
Monitor monthly. Check posterior contacts with articulating paper and look for adverse occlusal change throughout therapy.
Correct by occlusal settling. Grind about 1 mm from the posterior splint every 4–6 weeks to allow vertical eruption and leveling; keep the ARS another 1–3 months; complete when occlusion is stable and the mandible does not relapse after about 6 weeks without the splint.
Technique and timing for grinding. Begin only after the disc-protection phase (about 3 months full-time, or 6 months of basic wear in adult step-back protocols) once MRI or clinical findings confirm a maintained disc–condyle relationship and good bilaminar-zone adaptation. At each visit, ask whether the back teeth touch and verify with articulating paper (about 40 µm). Grind gradually, never abruptly: hastily flattened surfaces let the mandible drop too far back and joint symptoms recur. Some protocols skip incremental grinding and simply drop from full-time to night-only wear after 3 months, with the occlusion re-establishing over 1–2 weeks.
For a persistent molar open bite over 2 mm in adults with good or moderate bilaminar-zone adaptation on MRI, use step-back ARS retraction toward a stable occlusion; below 2 mm, a soft splint for at least 3 months. Consider equilibration, orthodontics or prosthetics if it does not resolve.
Cautions and limits
Tooth movement and open bite are the principal adverse effects to weigh against ARS benefit. ARS rarely achieves lasting disc recapture, and a flat-plane stabilization splint is a reasonable alternative that avoids the complication when the main goal is pain relief.
Some repositioning-phase occlusal changes were not maintained after orthodontic finishing in a classic Class II deep-bite case, so definitive closure can partially relapse.
Recurrence risk is high after stopping the splint: in one series only about 40% of patients with disc displacement with reduction maintained a normal disc–condyle relationship 6 months after ARS cessation, so confirm occlusal and symptomatic stability before final discontinuation. In step-back retraction the mandible is moved slightly back from the edge-to-edge position, a new construction bite is taken, MRI confirms the disc–condyle relationship, and a new ARS is worn for 3 months; repeat until the molar gap is within 2 mm with confirmed tissue adaptation.
Weaning and closure evidence comes from small series and case reports; there is no standardized protocol for the magnitude or timing of grinding or step-back retraction.
Evidence summary
Limited. Case series, small clinical studies, a case report and guideline-level text.
Suspected lateral pterygoid myostatic contracture after anterior repositioning splint wear
Scope: Graded reversal of the protrusive position with exercise and manual therapy when a posterior open bite or inability to re-seat into maximum intercuspation is attributed to adaptive shortening of the lateral pterygoid muscle (LPM). No protocol validated specifically for ARS-induced contracture was identified; this approach is extrapolated from general TMD exercise and manual-therapy evidence and one LPM training trial.
Use when
After prolonged anterior repositioning splint wear the mandible will not return to maximum intercuspation.
A posterior open bite persists after splint withdrawal.
Protocol
Reverse the provocative posture gradually. Taper the anterior position by progressive posterior grinding of the splint (about 1 mm every 4–6 weeks), keep the splint another 1–3 months until occlusion is stable and does not relapse after about 6 weeks splint-free, and shift from full-time to night-only wear early to interrupt continuous protrusive loading.
LPM-directed exercises. In the LPM training trial (disc displacement with reduction), patients performed once daily 5–6 repetitions per side of: coordination training for lateral movement (a spatula held loosely between the teeth while moving the jaw right and left in front of a mirror) and static stretching with isometric contraction (palm on the temple or fist at the chin, resisted lateral movement, concentric then eccentric work against moderate resistance).
Add a mobility and stretching layer. Mandibular mobility exercises, masticatory-muscle stretching held about 10 seconds, post-isometric relaxation and friction massage, typically 10 repetitions each, with soft-diet and jaw-rest counseling.
Consider intraoral soft-tissue release. A gloved index finger passed along the lateral pharyngeal wall behind the last molar, applying posterior-cephalad pressure over the pterygoid origin, held about 5 seconds and repeated 5–6 times, combined with extraoral massage along and across the muscle fibers. Combine manual therapy with exercise and education rather than using it alone.
Close a refractory open bite definitively by equilibration, orthodontics or prosthetics when it does not resolve, recognizing that not all repositioning-phase changes are retained after finishing.
Cautions and limits
Evidence is minimal: no study validates this approach for ARS-induced contracture, and the LPM-specific trial concerned disc displacement with reduction, not post-splint contracture.
The premise that LPM dysfunction drives TMD lacks rigorous support; EMG studies show both heads are electrically silent at rest, so claims that targeted LPM therapy corrects a specific contracture should be made cautiously.
Exercise therapy improves pain, pressure-pain threshold and mouth opening in TMD, and adding exercise to splint therapy outperforms splint alone, but the Cochrane review notes substantial heterogeneity and insufficient data on optimal dosage.
Botulinum toxin has been described for LPM hyperactivity or dystonia, but it treats hyperactivity rather than established myostatic shortening and has not been evaluated for post-ARS contracture; if considered, it is for persistent muscle-driven cases only.
Evidence summary
Minimal. Extrapolated from a Cochrane review of exercise therapy, small randomized trials of exercise and manual therapy, anatomic and physiologic reviews of the LPM, and a classic case report on repositioning followed by orthodontics.
Canine guidance versus group function in splints and occlusal schemes: what the EMG evidence supports
Scope: Interpreting electromyographic (EMG) and disclusion-time evidence when choosing an excursive guidance scheme for a stabilization splint or occlusal adjustment.
Use when
Choosing canine guidance or group function for a stabilization splint.
Counseling on whether building canine guidance will reduce muscle load or improve TMD outcomes.
Protocol
Know what the laboratory evidence shows. In small EMG studies, canine guidance reduced elevator-muscle activity during clenching (static and lateral) compared with group function, chiefly in the mediotrusive-side temporalis; simulated overlays ranked canine-protected occlusion lowest, then semi-group function, group function, and group function with a balancing contact, with less non-working-side condylar displacement. In edentulous patients, anterior-guided dentures produced lower masseter and temporalis activity than bilateral balanced occlusion.
Note that the effect is parafunctional, not functional. Converting group function to dominant canine guidance reduced elevator activity during maximal lateral clenching but did not change activity during unilateral chewing.
Use disclusion time as a descriptive measure. The painful side in unilateral TMD showed longer disclusion time with more balancing-side temporalis activity and force. Computer-guided disclusion time reduction shortened disclusion time substantially and was associated with lower salivary cortisol, but EMG moved toward normal rather than simply falling, so lower EMG is not uniformly the therapeutic target.
Build canine guidance into a stabilization splint as a reasonable default for reducing parafunctional elevator loading, while recognizing that this rationale is biological and mechanistic.
Counsel honestly. No guidance scheme has been shown to produce superior clinical TMD or bruxism outcomes, so do not promise that canine guidance will resolve symptoms, and avoid deliberately building canine guidance into natural dentition for TMD prevention.
Cautions and limits
A systematic review of 16 studies (620 participants) found that canine-guidance splints improved pain, mouth opening, sleep and muscle activity versus no therapy, but head-to-head no guidance type was significantly superior for any outcome.
No longitudinal evidence shows that any functional occlusal scheme is superior for preventing or treating TMD, and deliberately creating canine guidance carries esthetic and stability tradeoffs.
Reduced EMG on canine-guided splints coexists with no change during chewing; the data do not suggest a physiological advantage of canine guidance in natural function, and no epidemiologic association between canine guidance and TMD was found.
The EMG studies are small (for example 6 and 20 subjects) and laboratory-based.
Evidence summary
Limited. Small EMG laboratory studies, a prospective single-arm study and a cross-sectional comparison, a systematic review finding no superiority of any guidance scheme, and narrative reviews.
Stabilization splint: chairside delivery sequence and recall adjustment
Scope: Stepwise occlusal adjustment at delivery of a maxillary stabilization splint and rebalancing at follow-up as the mandible settles.
Use when
Delivering a hard acrylic full-arch stabilization splint.
Planning recall visits after delivery.
Protocol
Verify complete, passive seating first. Before any occlusal adjustment, confirm the splint seats fully with acceptable retention. Relieve proximal tightness or over-retentive buccal areas with a slow-speed carbide bur until it seats passively and feels stable.
Mark centric contacts. With the patient reclined and guided into centric relation or comfortable closure (chin-point guidance or an anterior reference platform helps give a reproducible position), mark contacts with blue articulating ribbon; they should fall on the mandibular functional cusp tips and incisal edges.
Equilibrate to even bilateral contacts. Reduce premature or heavy marks until all posterior supporting cusps contact simultaneously with equal intensity on both sides, giving a flat, smooth occlusal plane. The aim is not to alter jaw position or load teeth orthodontically.
Establish canine or anterior guidance. With contrasting (red) ribbon, have the patient perform lateral and protrusive excursions. Eliminate working-side, non-working-side and protrusive posterior contacts, leaving smooth guidance carried by the canines without disturbing the centric stops. Movements should glide freely without a boxed-in feeling.
Polish and instruct. Polish adjusted surfaces and give wear and hygiene instructions.
Recall about every 2 weeks at first. As the elevator muscles relax, the mandible usually settles into a more seated position, previously even contacts become uneven and new prematurities appear. Re-mark and re-equilibrate at each visit and re-verify clean guidance with no returning posterior interferences. Re-record a CR bite or intraoral scan where useful, and track symptoms and palpation.
Endpoint. Continue until the jaw relationship is consistent and contacts no longer shift across several consecutive visits, then extend recall intervals and, if appropriate, taper wear.
Cautions and limits
Do not adjust the splint to deliberately change jaw position or move teeth; the aim is passive stabilization, and full-arch coverage with careful balancing prevents unwanted occlusal change.
Avoid isolated heavy contacts or posterior excursive interferences, which can create new interferences and worsen muscle dysfunction.
Evidence supporting a specific adjustment protocol is limited; the sequence reflects published delivery protocols, a Cochrane review and small clinical studies.
Evidence summary
Limited. A published delivery protocol with an anterior platform, a pilot comparison of fabrication techniques, small clinical and randomized studies of condylar and symptom change after splint therapy, a Cochrane review and guideline-level text.
Non-working-side (balancing) interferences: muscle activity, joint loading and clinical significance
Scope: What the biomechanical and EMG evidence supports about non-working-side contacts, to guide splint design and occlusal adjustment without overstating causation.
Use when
Deciding whether to eliminate balancing contacts on a splint or in natural dentition.
Counseling a patient who has been told an interference is causing their TMD.
Protocol
Know the muscle findings. In classic EMG work, introducing a hyperbalancing contact altered muscle activity and coordination during maximal lateral clenching, with a shift of temporalis activity toward the interference side and unchanged bilateral masseter activity; the authors noted this redistribution may affect temporomandibular joint reaction forces. Canine guidance altered clenching activity but not chewing.
Know the joint-loading findings are mixed. The intuitive fulcrum concept (a balancing contact distracting the ipsilateral condyle and overloading the contralateral joint) is not supported by all data. Several studies found non-working-side contacts reduced non-working-side condylar load or displacement, were associated with fewer joint sounds, or prevented compression, and bilateral balanced occlusion minimized displacement on both sides. Displacement differences are small and of uncertain clinical significance.
Do not promise unloading. Because the closing muscles lie posterior to the tooth contacts, the condyle experiences compressive force regardless of contact scheme, so no occlusal arrangement truly unloads an inflamed joint. Asymmetric loading from unilateral bite points is biomechanically plausible, and finite-element models show that unilateral disc displacement and favoring the asymptomatic side can shift stress to the contralateral joint.
Eliminate non-working interferences on splints as a reasonable default, to avoid asymmetric parafunctional muscle loading, while framing it as biomechanical reasoning rather than a proven TMD cure or preventive measure.
Individualize. Patients without a TMD history adapt well to artificial interferences, whereas those with a history and relevant psychological traits show more signs and symptoms, so individual vulnerability, not the interference itself, appears to drive the response.
Cautions and limits
The once-dogmatic view that non-working interferences are uniformly detrimental to the joint is not supported; epidemiologic and longitudinal correlations with TMD signs are too weak for clinically relevant conclusions, and there is no universal agreement on which interference is detrimental.
Increased muscle activity from premature contacts is not evidence of causation; any association between static occlusion and TMD is small and inconsistent, and occlusal treatment has not demonstrated efficacy for TMD.
Much of the data are small laboratory, simulation and finite-element studies; a systematic review found no guidance scheme superior for TMD outcomes.
Evidence summary
Limited. Small EMG and simulated-interference studies, biomechanical and finite-element modeling, narrative reviews, a systematic review of splint guidance schemes and guideline-level text.
Occlusal adjustment and equilibration for TMD: the conflicting evidence
Scope: Summary of what randomized-trial evidence says about selective occlusal adjustment, including removal of non-working-side interferences, as a treatment or preventive measure for TMD.
Use when
A patient or colleague proposes grinding the teeth to treat TMD pain.
Deciding whether to adjust interferences beyond refining a splint.
Protocol
State what has and has not been tested. No controlled trial has isolated removal of non-working-side interferences as the intervention; trials concern selective occlusal adjustment or equilibration as a whole.
Know the traditional conclusion. The 2003 Cochrane review (6 randomized trials) found no evidence that occlusal adjustment treats or prevents TMD; earlier qualitative systematic reviews found it comparable or inferior to control treatments while splints fared somewhat better; and reviews have concluded it cannot be recommended for management or prevention of TMD. Burket's Oral Medicine states that evaluation of occlusion and correction of occlusal abnormalities are not part of standard TMD treatment.
Know the 2024 Cochrane update. The updated review of occlusal interventions again rated evidence as very low certainty across most comparisons, so it does not establish a clinically meaningful benefit over no treatment.
Disclose the recent countercurrent. A 2025 meta-analysis of 11 randomized trials found higher odds of pain mitigation with occlusal adjustment than with mock adjustment (OR 0.67, 95% CI 0.51–0.88), with larger effects for facial and jaw pain, but flagged high risk of bias in several trials. A 2026 reanalysis of a randomized trial of physiologically oriented occlusal equilibration versus placebo in refractory chronic jaw pain (n = 77) reported higher odds of at least a 2-point pain reduction at 3 and 6 months; that protocol aimed to eliminate premature contacts and obtain balanced occlusion, a different philosophy from simply removing non-working contacts.
Sequence care accordingly. Because adjustment is irreversible, exhaust reversible, low-risk therapies first (self-management, splints, physical therapy, pharmacotherapy). Eliminating non-working interferences is defensible when refining a splint or correcting a frank iatrogenic interference, but it is not an evidence-supported stand-alone TMD treatment.
Cautions and limits
The discrepancy between the long-standing null reviews and the 2025–2026 positive analyses should be disclosed to patients rather than resolved in either direction.
The newer positive meta-analyses warrant reconsideration but do not yet overturn the standard of reversible therapy first, given their acknowledged bias.
The biomechanical rationale for removing balancing interferences is plausible but untested as an isolated maneuver.
Evidence summary
Conflicting and low certainty. Cochrane reviews (2003 and 2024), qualitative systematic reviews, narrative reviews, a 2025 meta-analysis of randomized trials and a 2026 reanalysis of one randomized trial.
Conservative first-line management of myogenous TMD
Scope: Sequencing of reversible therapies for myogenous temporomandibular disorder before any irreversible or invasive treatment, within a biopsychosocial framework.
Use when
A patient presents with masticatory muscle pain from TMD.
Deciding when to escalate to injections, irreversible occlusal treatment or surgery.
Protocol
Start with education and self-management. Reassurance about the benign, self-limiting nature of most TMD, jaw rest, soft diet and reduction of parafunctional habits. In a network meta-analysis of chronic TMD pain, usual care (home exercise, self-stretching, reassurance) itself gave a clinically meaningful pain benefit over placebo (risk difference 23–30%). The interventions with the best evidence are those promoting coping and movement rather than passive or irreversible treatments.
Add physical therapy. Therapist-assisted jaw mobilization (risk difference 36%) and manual trigger point therapy (32%) were among the most effective for pain; supervised jaw exercise with manipulation and mobilization improved function. An exercise meta-analysis showed a moderate pain reduction (SMD −0.58, about 1 point on a 10-point VAS, above the minimal clinically important difference) and higher pressure pain thresholds, and adding exercise to splint therapy outperformed splint alone. Cervical rehabilitation is a useful adjunct in myogenous TMD.
Integrate behavioral therapy early. Cognitive behavioral therapy augmented with biofeedback or relaxation was the most effective single intervention for pain in the network meta-analysis; it is especially relevant with anxiety, depression or chronic pain features.
Use short-term pharmacotherapy as an adjunct, on a fixed schedule at the lowest effective dose for the shortest duration: naproxen 500 mg twice daily; cyclobenzaprine 10 mg at bedtime for about 3 weeks (drowsiness limits use); amitriptyline 25 mg at bedtime (nortriptyline if anticholinergic effects are intolerable). In a network meta-analysis of muscular TMD, magnesium sulfate ranked first, then botulinum toxin A, cyclobenzaprine and clonazepam, all on low or very low certainty evidence; local anesthetics ranked below placebo. Avoid opioids and routine benzodiazepines.
Use a hard stabilization splint as a reversible adjunct, ideally with counseling; certainty is moderate to very low and benefit over controls is inconsistent.
Escalate only after these fail. Reserve injections, irreversible occlusal treatment and surgery for patients who do not respond; symptoms tend to improve over time and surgery is ultimately needed in only about 5% of cases.
Cautions and limits
Pharmacological evidence is mostly low or very low certainty, and drugs supplement rather than replace nondrug therapy.
Opioids carry dependence risk, and routine benzodiazepines such as diazepam carry addiction risk with modest benefit.
Botulinum toxin for myogenous TMD is described in narrative reviews with management recommendations, but certainty of benefit is low.
Evidence summary
Moderate for exercise, manual therapy and CBT (network meta-analysis, umbrella review, Cochrane and other meta-analyses); low to very low for pharmacotherapy, splints and botulinum toxin.
Botulinum toxin A for refractory myogenous TMD: indications, technique and risks
Scope: Off-label use of botulinum toxin type A (BoNT-A) for masticatory muscle pain that has failed conventional reversible therapy.
Use when
Myogenous TMD has failed documented conservative, reversible therapy, particularly with significant bruxism or parafunction or comorbid headache.
A patient asks about botulinum toxin for jaw pain or bruxism.
Protocol
Confirm refractoriness and consent. BoNT-A is not FDA-approved for TMD or bruxism; use is off-label and should follow a documented failure of conservative therapy. It should never be first-line.
Disclose the conflicting evidence. A meta-analysis of 15 randomized trials (504 patients) found lower pain than placebo at 1 month (mean difference −1.92) and 6 months (−2.08), with a bilateral dose of 60–100 U appearing optimal and no significant excess of adverse events. Another meta-analysis found no significant pain difference at 1, 3 or 6 months and no improvement in mouth opening, occlusal force or bruxism events, concluding the data do not support routine use. An umbrella review emphasized divergent trials and a high probability of adverse effects.
Know the product and indication. OnabotulinumtoxinA is the most-studied formulation for this use. Its FDA-approved orofacial-relevant indication is chronic migraine prophylaxis (the PREEMPT protocol, which includes temporalis injection), not TMD. Doses are brand-specific and not interconvertible with other toxins such as abobotulinumtoxinA or incobotulinumtoxinA. A 2025 prospective cohort (35 patients, masseter plus temporalis) reported clinically relevant pain and quality-of-life improvement by 1 month, sustained to 6 months, but no change in mandibular function or mouth opening.
Choose target muscles and dose. Most literature supports the masseter and anterior temporalis. Efficacy is typically reported with 25–50 U onabotulinumtoxinA per masseter over 1–3 sites; a refractory-myofascial-pain trial used 80 U total (30 U per masseter, 10 U per anterior temporalis, 5 injections per muscle spaced 5 mm apart with aspiration before each). Pterygoid injections may require EMG guidance; the superficial masseter does not. No standardized protocol exists.
Technique. Inject perpendicular with a 30-gauge needle after the patient clenches to delineate the muscle. Start low and titrate between visits to the lowest effective dose. Inject bilaterally with equal units if symptoms are bilateral, or use 20–50% less on the less-affected side if asymmetric. Stay below the ear-to-oral-commissure line and avoid the anterior border zone to prevent diffusion into the risorius and zygomaticus (smile asymmetry).
Set expectations. Effect begins about 2 weeks after injection and lasts roughly 4–6 months, which guides retreatment intervals; in a crossover trial pain fell from severe to minimal by 1 month, with benefit waning around month 4.
Counsel on common adverse effects. Masseter atrophy with chewing discomfort or weakness, transient bruising, perioral swelling, speech changes and asymmetric smile (technique-related).
Counsel on risks of repeated dosing. Masseter and temporalis atrophy, fatty replacement, reduced bite force and masticatory performance, and reduced mandibular bone density or volume. Masticatory muscle atrophy reduces mechanical loading and is associated with decreased mandibular cortical bone thickness and quality and condylar or alveolar bone loss, shown in animal models and some human CT studies and more pronounced in postmenopausal women. No prospective studies have characterized the long-term consequences, so counsel patients before repeated cycles and use caution.
Cautions and limits
Evidence quality is low to moderate and conflicting; no guideline defines a standard dose or interval.
Reserve BoNT-A for refractory cases; it treats hyperactivity rather than established myostatic shortening or joint pathology.
Document off-label status and informed consent, including long-term muscle and bone risks.
Evidence summary
Conflicting, low to moderate certainty. Meta-analyses with opposite conclusions, an umbrella review, a Cochrane review for sleep bruxism, small randomized trials and narrative reviews.
Silver Diamine Fluoride (38% SDF): Caries Arrest Versus Prevention
Scope: Use of 38% silver diamine fluoride for arresting cavitated carious lesions and, with weaker evidence, preventing new caries. In the US, SDF is FDA-cleared only for adult dentin hypersensitivity, so caries use is off-label.
Use when
C
o
u
n
s
e
l
i
n
g
o
r
s
e
l
e
c
t
i
n
g
p
a
t
i
e
n
t
s
f
o
r
S
D
F
,
p
a
r
t
i
c
u
l
a
r
l
y
c
h
i
l
d
r
e
n
,
p
a
t
i
e
n
t
s
w
h
o
c
a
n
n
o
t
t
o
l
e
r
a
t
e
r
e
s
t
o
r
a
t
i
v
e
c
a
r
e
,
a
n
d
c
a
v
i
t
a
t
e
d
l
e
s
i
o
n
s
w
i
t
h
o
u
t
p
u
l
p
i
n
v
o
l
v
e
m
e
n
t
.
Protocol
Frame the indication as arrest, not prevention. The strongest evidence and guideline support are for arresting existing cavitated lesions. Evidence for preventing new caries is weaker and inconsistent.
Follow the ADA guideline. The ADA strongly recommends 38% SDF twice a year over weekly 5% NaF varnish to arrest advanced cavitated coronal lesions in primary teeth (moderate certainty). The recommendation is conditional for permanent teeth (low certainty). The AAPD gives a conditional recommendation (low-quality evidence) for 38% SDF to arrest cavitated lesions in primary teeth, as part of a comprehensive caries management program, and the AAP agrees.
Apply at the evidence-based concentration and interval. Arrest rates are about 60-90% with repeated applications. Every 6 months, 38% outperformed 12%, and twice-yearly application gives higher arrest rates than once yearly. The Cochrane 2024 review found SDF arrested more surfaces than placebo or no treatment in primary teeth (MD 0.86 surfaces; low certainty).
Counsel on staining and obtain consent. Black staining of treated lesions is the main adverse effect. Skin contact stains temporarily, and mucosal contact can cause irritation for about 48 hours. Protect soft tissues during application.
Screen contraindications. Silver allergy. SDF is not indicated for lesions involving the pulp.
Reassess and reapply. Check lesion hardness at follow-up and reapply as needed.
Describe prevention evidence accurately. A Cuban trial (n=452, low fluoridation, high caries) reported fewer new decayed or filled teeth with 6-monthly SDF at 36 months (26.1% vs 49.7%; RR 0.52), but Cochrane rates primary-dentition prevention evidence as very low certainty, and one trial found no benefit over placebo on sound approximal surfaces (OR 1.12). Community programs have reported SDF performing about as well as sealants and ART at lower cost.
Cautions and limits
Other silver products, such as silver nitrate and silver nanoparticle agents, have far less clinical evidence than SDF.
Light curing after SDF is a separate, unsettled question (see the systematic review in the sources).
Reference-matching note: the Cuban trial figures and the community-program cost comparison were stated in the source answer but could not be matched to a specific listed reference, so they are not individually cited here.
Evidence summary
Guideline-supported (ADA strong/moderate for primary teeth, conditional/low for permanent teeth) for caries arrest; low-certainty Cochrane evidence overall; prevention evidence weak and inconsistent.
Botulinum Toxin Dosing: Masseteric Hypertrophy Versus Myogenous TMD
Scope: Comparison of onabotulinumtoxinA dosing and injection patterns for cosmetic masseteric hypertrophy and for myogenous TMD pain. Both uses are off-label for Botox, and no standardized protocol exists for either.
Use when
D
e
c
i
d
i
n
g
d
o
s
e
a
n
d
m
u
s
c
l
e
s
e
l
e
c
t
i
o
n
,
o
r
c
o
u
n
s
e
l
i
n
g
a
p
a
t
i
e
n
t
w
h
o
h
a
s
b
o
t
h
l
o
w
e
r
-
f
a
c
e
p
r
o
m
i
n
e
n
c
e
a
n
d
T
M
D
o
r
b
r
u
x
i
s
m
.
Protocol
Define the goal first. Hypertrophy: reduce muscle thickness and lower-face volume, masseter only. TMD: reduce pain and muscle hyperactivity, usually masseter with anterior temporalis (pterygoids occasionally).
Hypertrophy dosing. Per-masseter doses overlap with TMD, roughly 12-50 U onabotulinumtoxinA-equivalent per side. Carruthers phase 2 (onabotA, n=187): 24-96 U total all reduced lower-face volume versus placebo at day 90; retreatment at 6 months worked about as well as the first dose; no dose-related safety trends and no mandibular CT changes over 12 months; smile effects appeared only at 96 U. Botulax phase 2: at 12 weeks, 24, 48, 72 and 96 U total reduced clenched masseter thickness by 2.3, 3.4, 2.9 and 3.8 mm, and the authors concluded that 48 U or more is the most cost-effective dose. A meta-analysis (5 RCTs, n=536) found 48 U and 72 U both helped, but heterogeneity was substantial so an optimal protocol cannot be defined. In hypertrophy with bruxism (prabotulinumtoxinA), 35 U per side shrank the masseter most, and bruxism symptoms improved even at 15 U per side.
TMD dosing. About 25-50 U per masseter. Pooled data suggest 60-100 U total bilaterally gives the best pain benefit. A commonly reproduced refractory protocol is 80 U total: 30 U per masseter plus 10 U per anterior temporalis, 5 points per muscle. Retreatment about every 4-6 months, guided by symptoms. Start low and titrate up between visits to limit weakness.
Injection zone. Below the tragus-to-commissure line, at least 0.5 cm above the lower mandibular border, and between the anterior and posterior masseter borders, located while the patient clenches.
Convert units carefully. Units are brand-specific. The de Souza Nobre trial dilution corresponded to about 2.5 U Dysport per 1 U Botox. A survey reported Botox 30-100 U and Dysport 50-300 U per muscle in TMD practice.
Counsel the combined patient. Smile asymmetry at high doses, and reduced bite force and mandibular bone effects with repeated cycles, matter most when a cosmetic patient also clenches or has TMD and receives both treatments.
Cautions and limits
Neither use is FDA-approved for Botox; both are off-label.
Higher doses were linked to more 6-month pain relief in some TMD data, but RCTs conflict, and no formulation-adjusted dose-response is established for hypertrophy.
The source answer also stated that the De la Torre Canales trial compared 80, 140 and 200 U total. This conflicts with the 80 U single-regimen description cited elsewhere in the same answer, so it is not reproduced here; verify against the trial before citing.
Evidence summary
Mixed. Hypertrophy: phase 2 RCTs and a heterogeneous meta-analysis. TMD: conflicting meta-analyses. Dose-conversion figures come from a single trial's dilution.
Unilateral Chewing: Mandibular Lever Mechanics and Condylar Loading
Scope: Biomechanics of the mandible during unilateral biting and chewing, and the clinical implications of habitual chewing-side preference.
Use when
E
x
p
l
a
i
n
i
n
g
w
h
y
T
M
D
p
a
t
i
e
n
t
s
c
h
e
w
o
n
o
n
e
s
i
d
e
,
c
o
u
n
s
e
l
i
n
g
o
n
c
h
e
w
i
n
g
-
s
i
d
e
p
r
e
f
e
r
e
n
c
e
,
o
r
r
e
a
s
o
n
i
n
g
a
b
o
u
t
p
o
s
t
e
r
i
o
r
s
u
p
p
o
r
t
a
n
d
s
p
l
i
n
t
d
e
s
i
g
n
.
Protocol
Describe the lever correctly. In the sagittal view the mandible is usually described as a Class III lever: condyle as fulcrum, elevator muscles (masseter, medial pterygoid, temporalis) supplying effort between the joint and the teeth, bite point as load. Because the effort sits between fulcrum and load, the joint carries a reaction force, so condyles are not stress-free. In unilateral molar biting the frontal view matters more: the resultant muscle force passes between the bite point and the balancing-side condyle, so the contralateral TMJ takes most of the load.
Quantify with the right caveats. In unilateral molar biting, total condylar reaction force can exceed 75% of bite force, with up to 80% of that borne by the balancing-side condyle (primate-based biomechanical work). The further back the bite point, the shorter the load arm and the higher the mechanical advantage; incisal biting gives a long load arm and low mechanical advantage.
Know the experimental findings. With unilateral clenching the contralateral condyle moves upward, consistent with compression, while the ipsilateral condyle may distract with a second-molar bite. Moving a unilateral clench forward (premolar rather than molar) increased ipsilateral superior lateral pterygoid activity, interpreted as higher ipsilateral TMJ load.
Muscle recruitment. Masseter and medial pterygoid dominate on the working side. Anterior temporalis stays highly active on the non-chewing side and becomes more symmetric near closure, acting as a positioning muscle. Modeling shows higher temporalis energy on the non-working side, and simulated maximum muscle forces on the non-working side about 14% lower than on the working side.
Describe the in vivo joint-space finding. In an imaging study of mastication, joint space narrowed more on the balancing side than the working side (normalized minimum distance 0.74 vs 0.89; p<0.0001), regardless of bolus size, with loaded areas lateral in both joints. A thicker bolus (15 mm) widened joint space, meaning less joint compression. The working condyle stays more posterior throughout closure, linked to greater muscle force and functional load.
Note lateral pterygoid function. It moves the condyle forward, inward and downward, constraining lateral movement and unloading the disc during biting (from a biomechanical model of mandibles with a joint prosthesis).
Recognize remodeling on the preferred side. Chewing side preference is associated with condylar flattening, a larger horizontal condylar angle and a steeper articular eminence on that side. In degenerative joint disease, patients with chewing side preference show more osteoarthritic change on the preferred side, and TMD combined with chewing side preference was linked to worse condylar outcomes after stabilization splint therapy.
Treat the lever as a simplification. The joint is not stress-free, as early 'link' models proposed. Newer kinematic models combine lever, bell-crank and slider-crank mechanisms within a ligament-based tensegrity framework to explain the shifting axes of jaw rotation.
Apply the equilibrium principle. Muscle force equals bite force plus condylar reaction force; the nearer the bite point is to the muscle resultant, the smaller the joint load. In humans the condylar reaction force as a percentage of bite force is lower for incisal biting than in other primates.
Factor in facial morphology. Hypodivergent (short face): shorter, more robust ramus and more anterior center of force, giving greater mechanical advantage and higher bite force. Hyperdivergent (long face): lower bite force, with chewing using a greater percentage of maximum muscle effort, which may predispose to fatigue. A steeper mandibular plane and shorter ramus were associated with higher compressive joint stress. In finite element modeling, clockwise occlusal plane rotation increased condylar compressive stress, and a lower condylar height relative to the occlusal plane (angle alpha 21.07 degrees or less) was linked to higher risk of condylar osseous destruction.
Weigh the conflicting posterior-support evidence. Peck's validated finite element jaw model: removing molar contacts lowered total bite force and joint load, suggesting the neuromuscular system protects the joint by adjusting muscle activity. Peck's dynamic clenching model: with missing posterior teeth, condylar force nearly doubled compared with balanced occlusion. A patient-specific finite element study found higher, asymmetric TMJ stress with posterior tooth loss, particularly on the edentulous side. Clinically, shortened dental arches show no pain or mobility differences, only more joint sounds, which looks like adaptation rather than pathology.
Watch long-face patients. They may need closer attention to muscle fatigue and force distribution in restorative and splint design.
Explain painful-side chewing. Biting ipsilaterally offloads the painful joint because the balancing-side condyle carries more of the load.
Manage habitual unilateral chewing. Reported prevalence is 45-98%. It is linked to asymmetric EMG and sensorimotor changes and facial asymmetry, and is one of the few local factors associated with TMD; causality is not established. Retrain bilateral chewing with a soft diet for at most 2 weeks, then gradually return to normal textures. Smaller, softer boluses lowered TMJ disc stress in modeling.
Apply to restorative and splint design. An anterior-only splint without molar support raised the condyles considerably in experimental work because it moves the load anteriorly on the lever; posterior support limits this.
Cautions and limits
Hylander's 1975 paper is titled 'Lever or Link?' and the literature does not uniformly treat the human mandible as a simple lever; present the Class III model as a simplification.
Causality is not established: the sensorimotor and EMG asymmetries are documented but only suggest a predisposition. Chewing exercises can change chewing pattern, and orthodontic treatment can alter chewing side preference, especially in patients under 20 (single-study evidence).
The lateral pterygoid statement comes from a TMJ-replacement finite-element study, not a native-joint measurement.
Three listed references (Zheng 2024 theoretical model, Yamaguchi 2011 fMRI, Hannam 1981 medial pterygoid) were not tied to specific claims and are not added.
Conflict on painful-side chewing: the traditional view is that patients chew on the painful side to unload the ipsilateral condyle, but a 3D theoretical model predicts higher ipsilateral joint load during unilateral occlusion.
The source answer attributed the morphology (short-face/long-face) claims partly to a T-Scan occlusal-force study that does not obviously address them; the Gomes EMG study is the more direct support.
Peck's review DOI in the source answer (10.1111/joor.12345) looks like a placeholder, so that source links to a PubMed title search. Peck's licensed Wiley figure is omitted.
The load-share figures (75%, 80%) derive from primate and modeling work, not direct human in vivo measurement.
The Class III lever figure in the source answer was from a carnivore mandible (Wiley, licensed) and is omitted; its rodent-mandible paper is not cited.
Several statements in the source answer (anterior-only splint, retraining protocol) were not tied to specific references, so they are listed without individual citation.
Evidence summary
Biomechanical models, primate studies, EMG and small human experiments; chewing-side preference associations are observational. Low to moderate overall.
